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1 Introduction 
1.1 The immune system 
The immune system (from Latin: immunis = free, untouched) is the entirety of all organs, 
cells and proteins, which are used by an organism to defend itself from the threat of 
pathogenic invaders including viruses, bacteria and parasites, and harmful substances. The 
immune system is also responsible for recognizing and destroying pathological, transformed 
cells and for keeping healthy cells untouched. 
The first lines of defense against pathogens are natural barriers of the organism like 
epithelium of skin and mucosa. In case of failure of physical hurdles all vertebrates use 
innate and adaptive immune responses for recognition, clearance and protection from 
invading microorganisms.     
1.1.1 Innate immune responses 
The innate component of the vertebrate’s immune system is the most universal and most 
rapidly acting branch of the immune response, consisting of the complement system, 
phagocytic cells and soluble factors like interferons. For example, the C3b molecule, a 
fragment of the complement component C3, becomes attached on the surface of invading 
microorganisms. Subsequently phagocytic cells, equipped with surface receptors for C3b, 
recognize these labeled invaders and remove them by engulfment. Most phagocytosis is 
conducted by specialized cells such as macrophages, granulocytes and dendritic cells (see 
also chapter 1.2). Macrophages and dendritic cells (DCs) are further equipped with specific 
receptors – so  called Pattern Recognition Receptors (PRRs), which recognize conserved 
structural motifs of pathogenic microorganisms (see also chapter 1.3, (Janeway, 1989; 
Medzhitov and Janeway, 2000). Triggering of PPRs induces cytokine release, like the 
proinflammatory cytokines interleukin (IL)-1, IL-6, tumor necrosis factor (TNF)-α and type I 
interferons. A further important group of innate immune cells are natural killer (NK) cells. 
Even if NK cells seem not to express PRRs, they play an important role in the early response 
to tumors and infection with viruses or intracellular bacteria and.  
Defense against infection is based on the described players of the innate immune system. 
These host-resistance mechanisms are thought to be responsible for the major part of host 
defense (Zinkernagel, 2003). However, as pathogens have developed their own immune 
evasion mechanisms during co-evolution with the host immune system, innate immunity 
alone is often inadequate for their clearance.    
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1.1.2 Adaptive immune responses 
In case of failed elimination of invading microorganisms by the innate arm of the immune 
system, continuous production of inflammatory mediators leads to activation of adaptive 
immune responses. Unlike the innate component, which recognizes microorganisms via a 
limited number of germ line encoded receptors, pathogen detection of the adaptive immune 
system relies on a vast number of antigen receptors with unique specificities, which are 
generated via somatic recombination. 
T-lymphocytes (T-cells) are the main mediators of cellular adaptive immunity. These T-cells 
only recognize antigenic peptides that are bound to Major Histocompatibility Complexes 
(MHC), via their T-cell receptors. This limitation is called MHC restriction (Zinkernagel and 
Doherty, 1974). According to their surface markers T-cells can be subdivided in CD8+ T 
lymphocytes, also called cytotoxic T-cells (CTLs), which recognize antigens bound on MHC 
class I molecules for direct killing of virus infected or oncogenic transformed cells (Kagi et al., 
1994; O'Rourke and Mescher, 1992; Squier and Cohen, 1994) and CD4+ T-cells, also called T-
helper-cells, which recognize antigenic peptides bound on MHC class II molecules. CD4+ T-
cells further develop into TH1 or TH2 helper-cells. TH1 cells are mainly responsible for the 
activation of macrophages and the induction of inflammatory processes, whereas TH2 cells 
are anti-inflammatory and activate B-lymphocytes (B-cells), which start to develop into 
antibody-secreting plasma cells or into memory cells. The humoral branch of adaptive 
immunity is based on B-cells. As the most striking feature B-cells possess membrane located 
antibodies, the so-called B-cell receptor. The developmental program of B-cells includes a 
variety of gene rearrangement steps, which potentially lead to receptor specificities for any 
antigens they may encounter. After recognition of the cognate antigen, receptor-antigen 
complexes are endocytosed, proteolytically digested, bound on MHC class II molecules and 
presented to T-cells (Parker, 1993). The successful recognition by T-cells, in the presence of 
secreted mediators leads to clonal proliferation and differentiation of B-cells into antibody-
producing plasma cells or memory cells. In case of later infection with the same pathogen, 
the established immunological memory will induce a faster and more intensive immune 
response.  
1.2 Dendritic cells 
Dendritic cells are the most potent type of professional antigen presenting cells (APCs). DCs 
are central to the induction of innate and adaptive immune responses and are involved in 
inducing both CD4+ and CD8+ T-cell responses against antigens presented on MHC class I and 
MHC class II molecules, respectively (Steinman, 2007; Steinman and Banchereau, 2007). In 
contrast, other professional APCs like macrophages or B-cells (Table 1-1) and especially non-
professional APCs like thymic cortical epithelial cells or glia cells in the brain, which only 
express MHC class II molecules after stimulation (e.g. IFN-γ) are less efficient in inducing 
primary immune responses. DCs are also involved in tolerance processes in central and 
peripheral lymphatic organs (Mellman and Steinman, 2001; Steinman and Nussenzweig, 
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2002; Stockinger, 1999) and support the survival of naïve T-lymphocytes in the periphery 
(Brocker, 1997; Muranski et al., 2000). Furthermore, in the adaptive arm of immunity, DCs 
decisively regulate the outcome of T-cell responses, whereas in innate immunity DCs 
influence NK- and NKT-cells via secretion of the cytokine IL-12 or type I and II interferons. 
How DCs fulfill these multiplex, partially contrary tasks is not yet fully understood.  
Table 1-1 Specialization of different professional antigen presenting cells (adapted from (Belz et al., 2009) 
 Dendritic cells Macrophages B cells 
Antigen uptake Phagocytosis, 
Macropinocytosis 
Receptor-mediated 
endocytosis 
Phagocytosis, 
Receptor-mediated 
endocytosis 
Receptor-mediated 
endocytosis via 
immunoglobulin 
MHC II expression Constitutive high levels, 
inducible 
Low level expression, 
inducible 
Constitutive expression, 
inducible 
Antigen presenting 
function 
Activation of naïve  
T cells 
Recruitment of helper 
CD4
+
 T cells, 
Activation of naïve  
B cells 
Recruitment of helper  
T cells for antibody 
production 
 
 
DCs are a rare cell population constituting about 0.05% of total body cells, however they 
form an extensive network covering all tissues and organs of the body. These cells are 
specialized in sampling invaded microorganisms in the periphery, travelling via lymphatic 
vessels or the blood to the draining lymphoid organs and presenting their antigens to the 
cognate lymphocytes (Banchereau and Steinman, 1998). DCs use macropinocytosis (Sallusto 
and Lanzavecchia, 1994), phagocytosis (Inaba et al., 1992; Reis e Sousa et al., 1993; Svensson 
et al., 1997)  or receptor-induced endocytosis for uptake of antigens. In contrast to other 
phagocytes like macrophages, DCs sample their environment in a constitutive manner by 
uptake of high amounts of extracellular fluid. Additionally, DCs are equipped with specific 
uptake mechanisms using a variety of different receptors like DEC-205 (Jiang et al., 1995), Fc-
receptors (Dubois and Caux, 2005), collagen type I receptor and heat shock receptors like 
CD91 (Binder et al., 2000). Endocytosed proteins are not presented in an intact form, but 
rather as short peptides generated from the antigen by proteolytic digestion (Dubois and 
Caux, 2005; Wykes et al., 1998). Generally, peptides from exogenous sources are presented 
via MHC class II for interaction with the T-cell receptor of CD4+ T-cells, whereas 
intracellularly-derived peptides are bound in the groove of MHC class I and presented to 
CD8+ T-cells.  
DCs receiving any danger signal at the time of antigen acquisition convert from being 
specialized for antigen uptake to being antigen-presenting cells. This process, connected 
with a broad variety of phenotypic and functional changes, is called maturation (Banchereau 
et al., 2000). The ‘danger signal’ (Matzinger, 2001) for these changes can either come from 
microbial products like LPS or bacterial and viral nucleic acids (Cella et al., 1999; Rescigno et 
al., 1999). It can also originate from the host inflammatory response itself, for example 
stimulation by pro-inflammatory cytokines interleukin (IL)-6, IL-1β and TNF-α (Banchereau et 
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al., 2000). The levels of surface MHC-class II – peptide complexes then increase substantially 
and the half life of such complexes on the surface is prolonged from 10 to 100 hours (Cella et 
al., 1997). Simultaneously the expression of T-cell costimulatory molecules like CD80 (B7.1) 
and CD86 (B7.2) is induced, converting DCs to an activated, mature state. Subsequently DCs 
are no longer able to take up antigens via endocytosis. Thus they provide a snapshot of the 
hazardous antigen encountered initially (Pierre et al., 1997; Wilson et al., 2004). Therefore, 
depending on the maturation state, DCs can lead to either T-cell tolerance or to T-cell 
activation, which will result in adaptive immunity (Heath and Carbone, 2001). 
1.2.1 The Langerhans cell paradigm 
The previously described life history of dendritic cells, transforming from highly endoytotic 
immature cells in the periphery into strongly T-cell activating, but poorly endocytotic cells in 
the lymphoid organs, was originally derived from Langerhans cells (LCs), a DC type in the 
epidermis (Schuler and Steinman, 1985). Immature LCs exist in the skin dedicated to capture 
antigens and as a mature phenotype in the subcutaneous lymph nodes dedicated to present 
antigens to T-cells. The phenotypic changes during maturation together with specific tissue 
localization have been considered as a paradigm for all existing DCs. However, the life of DCs 
seems to be more complicated and most DC subtypes do not follow this simple “two-phase – 
two location” model. According to the LC paradigm, only immature DCs should be found in 
lymph nodes of infection-free mice. In reality even lymph nodes of such germ-free mice 
contain both immature and mature DCs, which is clearly in contradiction to the LC paradigm 
and may reflect distinct pathways of DC life history (Wilson et al., 2008). Indeed, recent 
research has revealed that DCs are not a homogeneous cell population but rather a network 
of different subtypes that are functionally and spatially distinct. Understanding diverse 
functionality of different DC subsets is not only of academic interest, but also becomes 
important for DC targeted immune therapies. Especially after the unsuccessful use of 
monocyte-derived DCs in immunotherapy, it has become clear that an increased knowledge 
of DC subsets and their function in health and disease will be of high importance for their 
clinical application. 
1.2.2 Dendritic cell subsets of the mouse: a classification 
As described above, DCs are a rare cell type located in blood, skin and all lymphoid tissues. 
These cells play a crucial role in normal immune responses, because mice depleted of DCs, 
display severe defects during bacterial and viral infections (Ciavarra et al., 2006; Jung et al., 
2002). Mouse lymphoid organs and blood contain two distinct subtypes of DCs: conventional 
and playmacytoid DCs. Here I will focus mainly on DCs from the spleen. 
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1.2.2.1 Plasmacytoid dendritic cells 
The family of circulating DCs consists of plasmacytoid DCs (pDCs), which exist in steady state 
as rounded cells, and which are characterized by expression of CD45RA and intermediate 
levels of CD11c (O'Keeffe et al., 2002a). Phenotypically distinct subsets have been reported, 
which can be separated by CD4 and CD8  expression (O'Keeffe et al., 2002a; Yang et al., 
2005).  They are found both in lymphoid and peripheral tissues and circulate within the 
blood stream (O'Keeffe et al., 2003). Upon activation pDCs acquire the typical DC 
morphology, which is accompanied by the secretion of large amounts of type I interferon 
(IFN) and are hence known as interferon-producing cells (Liu, 2005). This activation is caused 
by exposure to viruses, DNA, RNA or synthetic mimetics thereof in the form of TLR ligands 
like CpG-DNA (Krug et al., 2001) or single stranded (ss)RNA (Diebold et al., 2004), TLR9 and 
TLR7 agonists, respectively. There are indications that pDCs in different tissues function 
differentially:  TLR9 was reported to be crucial for detection of herpes simplex virus 1 (HSV-
1) in splenic pDCs, whereas pDCs of the bone marrow (BM) can respond both in a TLR9 
dependent and independent manner (Hochrein et al., 2004).  
There is no doubt that pDCs have an important function in innate immune responses due 
their outstanding ability to rapidly produce high levels of type I IFN (Barchet et al., 2005a; 
Barchet et al., 2005b). How pDCs are able to stimulate naïve T cells is still controversial and 
discussed at length in the literature. New potential roles of pDCs in antigen capture, 
processing, presentation and presentation to T cells at sites of infection have recently been 
reported (Villadangos and Young, 2008; Young et al., 2008). 
1.2.2.2 Resident, conventional dendritic cells of the spleen 
Around 1% of total splenocytes are DCs, of which approximately 80% belong to conventional 
(cDCs) and the remaining 20% to pDCs. Resident cDCs can be divided into three subsets 
according to their expression of the CD8  homodimer and the CD4 molecule: CD4+CD8 -, 
referred to as CD4+ cDCs, CD4-CD8 +, referred to as CD8 + cDCs, and CD4-CD8 -, referred to 
as double negative (DN) cDCs (Vremec et al., 2000; Vremec et al., 1992). The resident DCs 
from the spleen develop directly from bone marrow derived precursors within the lymphoid 
organs without any trafficking through peripheral tissues and keep – in the absence of any 
infection – an immature phenotype throughout their entire lifetime (Wilson et al., 2003). 
The “immature” phenotype still expresses high levels of MHC class II on the cell surface 
relative to other hematopoietic cells. 
1.2.2.2.1 CD8  conventional dendritic cells 
CD8  expression can be found on around 25% of all CD11chi cDCs as an  homodimer 
rather than as an αβ heterodimer expressed on T cells (Vremec et al., 1992). These CD8 + 
cDCs reside, unlike other cDCs, in the T cell area of the spleen in the steady state (De Smedt 
et al., 1996), and correspond most probably to the interdigitating cell (IDC), which has been 
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described earlier (Agger et al., 1992; Veerman and van Ewijk, 1975). With a life span of about 
3 days, CD8 + cDCs are the shortest lived splenic cDC population. One hallmark of CD8 + 
cDCs is their ability to secrete enormous amounts of the pro-inflammatory cytokine IL-12p70 
upon activation (Hochrein et al., 2001; Reis e Sousa et al., 1997). This cytokine leads to TH1 
priming of CD4+ T cells (Maldonado-Lopez et al., 1999). Additionally CD8 + cDCs secret IL-6 
and TNF-  (Proietto et al., 2004), and under certain circumstances even type I IFNs 
(Hochrein et al., 2001).  
CD8 + cDCs play a unique role in the maintenance of peripheral tolerance. During negative 
selection of T cells in the thymus, not all tissue specific antigens are expressed potentially 
leading to  autoreactive T cells (Starr et al., 2003). For the prevention of autoimmunity, 
peripheral mechanisms of tolerance are mediated by dendritic cells (Hawiger et al., 2001). 
There are indications that CD8 + cDCs are involved in this process (O'Keeffe et al., 2005a).  
In the classical pathway endogenous antigens are presented via MHC class I molecules and 
exogenous antigens via MHC class II molecules. However, this model does not explain how 
exogenous self-antigen can access the MHC class I pathway for induction of immunity and 
tolerance. One unique key feature of CD8 + cDCs is their exclusive ability to “cross-present” 
antigens. In this process exogenous antigens are directed towards the MHC class I pathway, 
enabling presentation to the TCR of CD8+ T cells (den Haan et al., 2000; Villadangos and 
Schnorrer, 2007). Cross-presentation clearly plays an important role in the context of CD8 T 
cell priming towards infection with lytic and non-lytic viruses and intracellular bacteria, 
tumor surveillance and maintenance of peripheral tolerance (Belz et al., 2005; Belz et al., 
2004; Chen et al., 2004; Heath et al., 2004). However the precise molecular mechanisms are 
still ill defined and remain controversial (Groothuis and Neefjes, 2005; Lin et al., 2008).   
CD8 + cDCs, unlike other cDCs of the spleen, absolutely require interferon response factor 8 
(IRF8, also known as ISCBP) for development and normal immune function (Tamura et al., 
2005). Additionally CD8 + cDCs uniquely express TLR3, enabling these cells to recognize 
dsRNA viruses. 
1.2.2.2.2  CD4  conventional dendritic cells 
CD4+CD8 - cDCs comprise around 50% of all splenic cDCs. In contrast to T cell area located 
CD8 + cDCs, CD4+ cDCs tend to be found in the marginal zones of the spleen (Agger et al., 
1992; Metlay et al., 1990). However, upon stimulation with TLR agonists like LPS, these cells 
redistribute to the T cell areas of lymphoid organs (Reis e Sousa et al., 1997).  
Compared to other cDCs, CD4+ cDCs produce the highest level of chemokines like Mip3 , 
Mip3  and RANTES (Proietto et al., 2004), even in a resting state. The functional significance 
of this chemokine secretion is still not fully understood.  
Contrary to CD8 + cDCs, CD4+ cDCs have been reported to induce TH2 response (Hammad et 
al., 2004; Maldonado-Lopez et al., 1999). The cross-presentation capability of CD4+ cDCs is 
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also very poor. However, CD4+ cDCs are the most potent presenters of antigens loaded on 
MHC class II molecules to CD4+ T cells (Pooley et al., 2001). Furthermore, CD4+ cDCs 
efficiently induce CD4+ T cell responses after antigen targeting via C-type lectin receptors 
such as Dectin-1 and DCIR-2 (Carter et al., 2006; Dudziak et al., 2007).  
Only a few reports are published analyzing the role of CD4+ cDCs in immunity against 
intracellular pathogens. It has been proposed that CD4+ cDCs play a role in immunity against 
microbes due their capability to produce TNF-  and iNOS (Serbina et al., 2003). However, 
the recent observation of de novo-formed DCs during inflammation make it is most likely 
that these functions have been incorrectly attributed to CD4+ cDCs (Lopez-Bravo and 
Ardavin, 2008). Therefore, it remains elusive whether or not CD4+ cDCs are crucial for the 
control of any particular infection.  
1.2.2.2.3 CD4-CD8 - conventional dendritic cells 
It has become common to group DN cDCs, about 25% of splenic cDC, which express neither 
CD4 nor CD8 , together with CD4+ cDCs and define this “new” subset as CD8 - cDCs. This is 
mainly justified due to similar gene expression profiles (Edwards et al., 2003a) and similar 
production of  Mip3 , Mip3  and RANTES (note that the levels produced in the steady state 
are considerably lower than those produced by CD4+ cDCs). Consistently DN cDCs are also 
poor in cross-presenting exogenous antigens, although they are as efficient as CD4+ cDCs in 
direct MHC class II presentation (Schnorrer et al., 2006). It was earlier believed that DN cDCs 
are able to produce high levels of IFN-γ, but this was later revealed to derive from a small 
population of precursor cells, which are frequently contaminants in DC preparations 
(Vremec et al., 2007).   
In spite of this evidence of close similarity between CD4+ and DN cDCs, IRF4, IRF2 (Tamura et 
al., 2005) or NF- Bp50 knockout mice (O'Keeffe et al., 2005b) show heavily reduced 
numbers of CD4+ cDCs, but much less reduction of DN cDCs. Moreover, mice treated with 
Flt3-ligand show a large increase in cell numbers of CD8 + cDCs and DN cDCs, but not CD4+ 
cDCs. It has to be mentioned, that these studies were performed when little solid knowledge 
of lineage development of functionally specialized DC subsets existed. The discovery that DN 
cDCs preparations can contain around 10% “contaminations” of precursor cells en route to 
the CD4-CD8 + cDC subtype, however not yet expressing CD8  homodimer, makes a careful 
reinvestigation of the functional properties of DN cDCs necessary (Vremec et al., 2007). 
Many of the above mentioned studies should be repeated using published antibodies like 
Sirp-alpha (CD172 ) (Naik et al., 2005) to get a “real” CD11chiCD4negCD8 negSirp hi DN cDC 
population. 
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1.2.3 In vitro models of dendritic cells 
Because dendritic cells are a very rare population in vivo it quickly became apparent that in 
vitro generation systems would greatly speed up research. Several cell culture methods have 
been developed.  
1.2.3.1 GM-CSF derived dendritic cells (GM-DC) 
In the human system in particular, difficulties in handling human tissues make an in vitro 
generation method for dendritic cells highly desirable. In both humans and mice, monocytes 
can differentiate into DCs. This fact has widely been taken advantage of by culturing human 
peripheral blood mononuclear cells (PBMCs) with the cytokines GM-CSF and interleukin-4 
(IL-4) (Sallusto and Lanzavecchia, 1994). Similarly, mouse bone marrow cells can differentiate 
in the presence of GM-CSF with or without IL-4 into CD11hi cells (Inaba et al., 1992; Lutz et 
al., 1999). The resulting human and mouse “monocyte-derived dendritic cells” are similar to 
each other and show a quite mature phenotype with relative high levels of MHC class II 
surface expression and co-stimulatory molecules. This method has become the standard for 
the generation of DC in vitro and as a consequence, monocytes or earlier precursors have 
long been acknowledged to be precursors of dendritic cells.  
While this method of generating DCs has undoubtedly enhanced knowledge of DC biology, 
nowadays it is becoming more and more obvious that these “monocyte-derived DCs” do not 
mimic the steady state cDC in vivo in all aspect. In fact, GM-CSF expression levels are 
basically undetectable in healthy humans and steady state mice. Therefore it is unlikely that 
low concentrations of GM-CSF can significantly contribute to the steady state generation of 
DCs from monocytes (Cheers et al., 1988; Metcalf, 1988). Also knockout mice lacking either 
GM-CSF or the receptor for GM-CSF show normal numbers of DC in spleen and thymus. 
Furthermore, the expected distribution of cDCs subsets in these knock out mice was 
indistinguishable from WT mice (Vremec et al., 1997). This means that monocytes can 
differentiate into dendritic cells, however in the steady state, this differentiation pathway is 
not used.  
The first clear evidence for an in vivo equivalent of “monocyte derived”-DCs emerged when 
a novel dendritic cell type was described in the spleen of Listeria monocytogenes infected 
mice. This DC type produced high levels of TNF-  and iNOS (inducible nitric oxide synthase) 
and was therefore named Tip-DC (Serbina et al., 2003). The phenotype of Tip-DCs is 
described as CD11cintCD11b+Mac-3+, clearly different from the CD11chiCD11blowMac-3- 
phenotype of steady state cDCs. Importantly, chemokine receptor 2 (CCR2) knockout mice 
could not generate Tip-DC, whereas cDC were not impaired. It is known that CCR2 is 
selectively expressed on a specific Ly6Chi monocyte subset (Geissmann et al., 2003), which is 
now acknowledged to be the precursor of inflammatory Tip-DCs. Finally, a recent study 
revealed that GM-CSF driven “monocyte-derived” DCs represent inflammatory Tip-DCs, 
rather than cDCs of the steady state (Xu et al., 2007).   
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1.2.3.2 Flt3-derived dendritic cells (FL-DCs) 
Another in vitro system uses Flt3-ligand (FL) to drive mouse bone marrow precursors into 
steady state DCs. Following the observations that FL treatment caused heavily increased DC 
numbers in living mice (Maraskovsky et al., 1996), and that FL knockout mice had abrogated 
DC numbers (McKenna et al., 2000), a novel cell culture system was devised using total BM 
cells supplemented with FL to generate high numbers of immature mouse DCs (Brasel et al., 
2000). Later it was found, that these cultures contain a large number type I interferon-
producing B220 positive cells, which were proposed to be equivalents of pDCs (Brawand et 
al., 2002). The recent finding that DCs of these cultures closely represent pDC as well as both 
CD8+ and CD8- conventional subsets of mouse spleens, strongly suggests the use of this 
system as the most representative model of splenic subsets (Naik et al., 2005). Using Sirp , 
an already proven marker in splenic DC research, easily separates FL-driven DC cultures into 
CD11c+CD45RAhi , CD11hiCD24hiSirp - and CD11hiCD24loSirp + as bona fide equivalents of 
splenic pDCs, CD8+ and CD8+ cDCs, respectively (Vremec and Shortman, 2008).  
1.3 Pathogen recognition 
Charles Janeway published a prescient paper in 1989, proposing that APCs and other innate 
immune cells possess pattern recognition receptor (PRRs) enabling the recognition of 
molecular signatures of possibly infectious organisms (Janeway, 1989).  
 
Figure 1-1 Schematic representation of the structure and main signaling pathways of the PRR families (adapted 
from (Rakoff-Nahoum and Medzhitov, 2009) 
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The target of PRRs is often referred to as “pathogen associated molecular patterns” 
(PAMPs), although they are also present on non-pathogenic microorganisms.  
PAMPs are very important for the innate immune system for three main reasons. First, 
PAMPs are invariant among microorganisms of a certain class. Second, PAMPS represent 
products unique to microorganisms, allowing discrimination between self and non-self 
molecules. Third, PAMPS play an essential role in microbial physiology, restricting the 
opportunities of microorganisms to evade immune recognition via evolutionary adaption. 
Charles Janeway was years ahead of the rest of the immunology field and it took until 1996 
that the first molecular component of a PRR was identified in drosophila adults and called 
“Toll” (Lemaitre et al., 1996). Just one year later, the first bona fide PRR, a human toll-like 
receptor (TLR), was cloned (Medzhitov et al., 1997). Today, various classes of PRRs have 
been identified besides TLRs, like nucleotide binding and oligomerization domain (NOD)-like 
receptors (NLRs), retinoid acid-inducible gene I (RIG-I)-like helicases (RLHs) and DNA 
receptors (Figure 1-1). TLRs are located on the cell surface and in endosomes, whereas NLRs, 
RLHs and the DNA receptors detect foreign components in the cytosol. Recognition of 
PAMPs by PRRs activates intracellular signaling cascades leading to DC maturation and type I 
IFN and proinflammatory cytokine production, which mediate the innate and adaptive 
immune response.  
1.3.1 Toll-like receptors 
The TLR family members recognize nucleic-acid, lipid, carbohydrate and peptide signatures 
which are broadly distributed in microorganisms. To date, a total number of 13 TLRs have 
been identified in mouse and man (Takeda et al., 2003). TLR1-9 are common to mice and 
humans, whereas TLR10 seems only to be functional in humans. TLR11-13 occur only in the 
mouse. TLR1, TLR2, TLR4, TLR5 and TLR6 are expressed on the cell surface, whereas TLR3, 
TLR7 and TLR9 are localized in the endoplasmic reticulum (ER) and move to endosomes or 
lysosomes upon stimulation. All TLRs are comprised of luminal leucine-rich repeats (LRRs) 
that sense PAMPS, a transmembrane domain and a cytoplasmic Toll/interleukin-1 (IL-1) 
receptor (TIR) homology domain.  The TIR domain couples the TLRs to four adaptors 
molecules, MyD88, TIRAP/MAL, TRAM and TRIF through homophilic interactions (Takeda et 
al., 2003). 
The first TLR to be discovered was TLR4, the cellular receptor for lipopolysaccharide (LPS), 
responsible for mediating the inflammatory response to Gram-negative bacteria (Hoshino et 
al., 1999). The lipid portion of LPS, called “lipid A” is known to be one of the most potent 
immunostimulants causing endotoxic shock. After invasion of Gram-negative bacteria, LPS 
associates with acute phase proteins present in the bloodstream and binds to CD14, 
expressed on the cell surface of phagocytic cells and in conjunction with MD-2 activates TLR4 
(Poltorak et al., 1998; Shimazu et al., 1999). But not only Gram-negative bacteria activate the 
innate immune system. The bacterial cell wall of Gram-positive bacteria contains lipoteichoic 
acid (LTA) instead of LPS (Takeuchi et al., 2000). In this case, TLR2, together with TLR1 and 
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TLR6, is mainly responsible for recognition (Ozinsky et al., 2000).  Table 1-2 gives a basic 
overview of several bacterial components recognized by a defined set of TLRs.  
Table 1-2 TLRs and their cognate bacterial ligands  
TLR Bacterial component Species 
TLR1/TLR2 Triacyl lipopeptides Bacteria / Mycobacteria 
TLR2 Peptidoglycan Gram-positive bacteria 
TLR2 Porins Neisseria 
TLR2 Lipoarabinomannan Mycobacteria 
TLR2/TLR6 Lipoteichoic acid Streptococcus 
TLR2/TLR6 Diacyl lipopeptides Mycoplasma 
TLR4 Lipopolysaccharide Gram-negative bacteria 
TLR5 Flagellin Flagellated bacteria 
TLR9 CpG-DNA Bacteria / Mycobacteria 
 
TLRs also recognize virus associated molecules. Viruses contain either DNA or RNA that 
encode structural components and enzymes, which are necessary for replication and further 
infection of cells. Various structural components, including, double-stranded (ds)RNA, single-
stranded (ss)RNA and viral DNA are recognized by TLR3, TLR7, TLR8, TLR9, whereas TLR2 and 
TLR4 recognize surface glycoproteins of viruses (Table 1-3).  
TLR3 was found to detect dsRNA by specifically recognizing purified genomic dsRNA (and the 
synthetic ligand poly(I:C)) (Alexopoulou et al., 2001) resulting in  induction of IL-12, IL-6, TNF-
 and IFN-ß. dsRNA is a PAMP which can be generated during viral infection as a replication 
intermediate of ssRNA viruses or as a transcriptional by-product of DNA viruses. 
TLR3 is expressed in a broad variety of epithelial cells, such as airway, vaginal, uterine and 
intenstinal epithelial cells, which function as barriers to infections. Unlike specialized 
immune cells like DCs, which express TLR intracellularly, these cells express TLR3 on their cell 
surface. Furthermore, astrocytes and glioblastome cell lines strongly express TLR3, indicating 
a specific role for TLR3 in the brain. Confusingly, TLR3 seems not be involved in the initial 
phase of viral recognition. Several reports showed, that TLR3 knockout mice did not show 
increased susceptibility to many viral infections like murine cytomegalovirus (MCMV), 
vesicular stomatitis virus (VSV), lymphocytic choriomeningitis virus (LCMV) and reovirus 
(Edelmann et al., 2004). Instead, interactions of West Nile virus with TLR3 seems even to be 
beneficial for the spread and survival of the virus (Wang et al., 2004). Further complicating 
the role of TLR3 in viral infection, it has been reported that TLR3 promotes crosspresentation 
of virus-infected cells (Schulz et al., 2005).  
TLR7 and TLR8 are both expressed in the endosomal membrane in human and mice, 
however mouse TLR8 appears to be non-functional. The key activator for these TLRs of both 
species are uridine-rich, or uridine-guanine-rich viral ssRNA (as well as synthetic compounds 
like antiviral imidiazoquinolines like R848 or imiquimod). The endosomal location seems to 
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be evolutionary ‘well chosen’, because many enveloped viruses traffic into the cytosol 
through the endosomal compartment and can be discovered in such way. Additionally, the 
proteolytic environment in endosomes digests the viral particles leading to release of ssRNA 
which can be recognized by TLR7 and TLR8.   
TLR9 is located in acidified, intracellular compartments and activated by ssDNA 
oligonucleotides bearing unmethylated CpG base pairs (Bauer et al., 2001) from viruses 
including herpes simplex virus 1 and 2 (HSV-1, HSV2) and MCMV. Optimal CpG motifs of 
synthetic compounds for murine TLR9 activation were found to be unmethylated CpG 
dinucleotides flanked by 5’ purines and two 3’ pyrimidines. Recently, the strict dependence 
of TLR9 on non-self CpG motifs was challenged by the discovery that 2’ deoxyribose is 
sufficient – independently of base sequences – to confer signaling specificity by TLR9 for 
DNA (Haas et al., 2008).  
For reasons of completeness it should be noted that besides the key viral activators of the 
immune system, viral DNA and RNA, some viral envelope proteins can also be recognized, 
mainly by TLR2 and TLR4. However, detection via TLR2 and TLR4 leads to induction of 
proinflammatoriy cytokines rather than to type I IFNs. For example, the fusion protein of 
Respiratory Syncytial Virus (RSV) or the envelope protein (ENV) of mouse mammary tumor 
virus (MMTV) activates TLR4 (Burzyn et al., 2004; Kurt-Jones et al., 2000).  
Table 1-3 TLRs and their cognate viral ligands 
TLR Viral component Species 
TLR3 dsRNA Viruses 
TLR7/TLR8 ssRNA RNA viruses 
TLR9 DNA Viruses 
TLR2 Hemaglutinin protein Measles virus 
TLR4 Envelope proteins MMTV, RSV 
1.3.2 RIG-like helicases 
Another family of PRRs shown to be involved in the recognition of viral RNA are the 
members of the RIG-like helicase (RLH) family, namely retinoic-acid-inducible gene I (RIG-I, 
also called DDX58), melanoma-differentiation-associated gene 5 (MDA5, also called Helicard) 
and laboratory of genetics and physiology-2 (LGP2) (Yoneyama and Fujita, 2007). Whereas 
RIG-I and MDA5 both contain a DExD/H box RNA helicase domain and two N-terminal 
caspase recruiting domain (CARD)-like domains, which is essential for downstream signaling, 
LGP2 lacks the CARD-like domains completely (Yoneyama et al., 2005).  
Several studies reported differential involvement of RIG-I and MDA5 in antiviral responses, 
whereas LGP2 was suggested to serve as a negative regulator of RIG-I (Rothenfusser et al., 
2005; Saito et al., 2007). RIG-I recognizes a wide variety of ssRNA viruses which include 
members of the paramyxoviridae like, Newcastle disease virus and Sendai virus, 
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rhabdoviridae like, VSV, and members of the flaviviridae like Japanese encephalitis virus 
(JEV) and hepatitis C virus (HCV). Picornaviruses, such as encephalomyocarditis virus (EMCV) 
and Theiler’s virus are specifically recognized by MDA5, as shown in MDA5 knockout mice. 
(Kato et al., 2006; Xagorari and Chlichlia, 2008).  
It has been reported that RIG-I and MDA5 recognize distinct types of RNA (Figure 1-2). The 
critical determinant for type I IFN induction by RIG-I stimulation through RNA was recently 
determined to be a 5’-triphosphate moiety, independently of single or double strandedness. 
Similarly, in vitro described RNA also contains a 5’-triphosphate and therefore leads to RIG-I 
activation (Hornung et al., 2006; Pichlmair et al., 2006). This strict requirement of 5’-
triphosphates also explains why RIG-I does not activate innate immune responses against 
host RNA. Cellular ssRNAs are normally capped or processed and therefore absent for the 
recognition motif.  However not only 5’-triphosphate specifically activates RIG-I but also 
dsRNA, lacking any 5’-triphposphates, initiates type I IFN secretion by RLHs. It has been 
shown, that poly(I:C), an artificial dsRNA generate by annealing pI and pC, which does not 
bear any 5’-triphosphates, activates cytosolic RLHs in a length dependent fashion: MDA5, the 
originally described agonist of p(I:C) (Gitlin et al., 2006) binds to long poly(I:C), whereas RIG-I 
preferentially binds shortened poly(I:C) (Kato et al., 2008). Furthermore long dsRNA, 
produced by EMCV infection trigger a MDA5-dependent IFN production.  
 
Figure 1-2  Differential recognition of RNA by RLHs receptors 
A recent report suggested that RIG-I also requires a polyuridine motif at the 3’-non-
translated region for recognition of HCV infection (Saito et al., 2008). If this applies also to 
the recognition of other viruses remains still to be determined. 
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1.3.3 NOD-like receptors 
The murine nucleotide oligomerization domain-like (NOD) receptor family comprises at least 
34 members, which are expressed in many different cell types, including immune and 
epithelial cells. NLRs were first identified in plant, where they play a crucial role in resistance 
against microbial and parasite pathogens (Dangl and McDowell, 2006). NLRs are in general 
composed of variable N-terminal domains, like caspase recruitment domains (CARDs), 
baculovirus inhibitor repeats (BIRs) or pyrin domains (PYD), which also define the subfamily 
classes (Inohara and Nunez, 2003). These are connected to a centrally located NOD (also 
called NACHT-domain), which plays a critical role in activation, and C-terminal leucine-rich 
repeats (LRRs), responsible for pathogen sensing (Figure 1-3). The NOD-domain shows 
similarities to the oligomerization module of ATPases, indicating that nucleotide hydrolysis is 
essential for activation (Hanson and Whiteheart, 2005). Indeed, mutations in conserved 
regions of the NODs NOD1, NOD2, NLRP3 and NLRP12 abolished signaling (Duncan et al., 
2007; Ye et al., 2008).  
 
Figure 1-3 Activation of inflammatory immune responses by NOD-like receptors 
Both NOD1 and NOD2 recognize bacterial molecules produced during degradation, synthesis 
or remodeling of peptidoglycan (PGN), a major component of bacterial cell walls. 
Specifically, NOD1 senses meso-diaminopimelic (meso-DAP)-containing PGN-fragments 
(Chamaillard et al., 2003), which are produced by most Gram-positive and a few Gram-
negative bacteria, including Listeria and Bacillus species (Hasegawa et al., 2006). NOD2 is 
activated by all types of muramyl dipeptide (MDP), which is found in the PGNs of nearly all 
bacteria. Following microbial sensing NOD1 and NOD2 recruit the serine-threonine kinase 
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RIP2, which is essential for signal transduction, as shown in RIP2 null mice (Kobayashi et al., 
2002), leading to NF- B activation.  
Deregulation of NOD1 and NOD2 signaling is involved in a variety of human diseases. There 
is mounting evidence that several NOD2 variants cause increased susceptibility to Crohn’s 
disease, a chronic disorder characterized by inflammation of the intestine (Hugot et al., 
2001; Ogura et al., 2001) and to Blau syndrome, an autosomal dominant disorder 
characterized by inflammation of the eyes, skin and joints (Miceli-Richard et al., 2001). 
Besides the activation of inflammatory cytokines and interferons via NF- B, certain members 
of the NLR family trigger caspase-1, an inflammatory molecule. Tschopp and colleagues 
coined the term “inflammasome” to describe a multiprotein complex leading to caspase-1 
activation. Depending on the stimulus, at least three inflammasomes of distinct composition 
are formed in vivo: the IPAF inflammasome triggered by Salmonella, Legionella and flagellin 
(Franchi et al., 2006; Mariathasan et al., 2004; Miao et al., 2006), the NALP1 inflammasome 
triggered by B. anthracis (Boyden and Dietrich, 2006), the NALP3 inflammasome triggered by 
non-microbial signals like uric acid crystals, asbestos and silica (Cassel et al., 2008; Dostert et 
al., 2008; Hornung et al., 2008; Mariathasan et al., 2006). Biochemical analysis revealed that 
IPAF directly binds caspase-1, whereas NALP1 and NALP3 associate with caspase-1 via the 
adaptor molecule ASC, both leading to subsequent processing of proinflammatory pro-IL-1ß.  
1.3.4 Dendritic cell subsets and pathogen recognition 
The separation of DCs into several subsets is based on their differential expression of surface 
markers, but these diverse subsets in most cases also correlate with functional differences. 
These functional differences amongst phenotypically different subsets are of major 
importance in understanding DC biology especially for manipulating the immune response to 
tumors, autoimmune diseases and pathogens. Functional diversity is thought to be mainly 
based on differential expression of certain PRRs. Especially TLRs, an ancient and highly 
conserved family of PRR involved both in pathogen recognition (Hochrein and O'Keeffe, 
2008) and autoimmune pathologies (Fischer and Ehlers, 2008) are known to be distinct 
distributed amongst mouse DC subsets (Table 1-4), as revealed by microarray analysis 
(Edwards et al., 2003a).  
As shown in Table 1-4 all DC subsets express a wide array of extra- and intracellular TLRs. 
However, some of them are more abundant in pDCs or cDCs, or even between cDC subsets. 
All cDCs express TLR2, TLR4 and TLR6, enabling them to respond to a variety of extracellular 
bacterial products such as LPS and lipopeptides, and also some coat proteins from different 
viruses like HSV-1, HCMV, RSV or MMTV.  
Within the TLR family for nucleic acid recognition TLR7 and TRL9 are more abundant in pDCs, 
enabling them to respond to a broad variety of viruses by producing high levels of type I 
IFNs. cDC subsets also express TLR9 and partially TLR7, however only pDCs are able to 
produce very high levels of IFNs. TLR3 is mainly expressed by CD8 + cDCs, which also 
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corresponds to their unique cytokine and chemokine secretion profile after stimulation with 
cognate ligands. The activation of TLR3 in CD8 + cDCs also enhances crosspresentation, a 
unique feature of this specific DC subset (Schulz et al., 2005). 
Table 1-4 Variation of TLR expression amongst different splenic DC subsets of mice (adapted from (Hochrein 
and O'Keeffe, 2008) 
 pDCs CD4+ cDCs CD8 + cDCs DN cDCs 
TLR1 ++ ++ ++ ++ 
TLR2 ++ ++ ++ ++ 
TLR3 low + +++ ++ 
TLR4 + + + + 
TLR5 + ++ low + 
TLR6 ++ +++ ++ ++ 
TLR7 +++ ++ neg + 
TLR8 ++ ++ ++ ++ 
TLR9 +++ ++ ++ ++ 
 
In addition to TLRs, other PRRs have been identified to be differentially involved in pathogen 
recognition amongst DC subsets. An example is the involvement of the cytosolic RNA 
helicases RIG-I and MDA5. It was shown recently that DC subsets use different mechanisms 
to sense direct viral infections: pDCs predominately detect viral infections via the TLR system 
(TLR7 and TLR9), whereas all cDC subsets use the cytosolic helicases RIG-I and MDA5 (Kato et 
al., 2005). This shows that RIG-I and TLRs exert antiviral responses in a dendritic cell type-
specific manner. 
1.4 Mass spectrometry in the field of protein analysis 
Mass spectrometry (MS) has emerged as a central analytical technique for protein research 
(Aebersold and Mann, 2003; Cravatt et al., 2007). After the discoveries made by whole 
genome sequencing it was clear that the nucleic acid data needed to be used to understand 
protein sequences and protein functions. However, this turned out to be not a trivial task! 
The systematic analysis of all proteins expressed in a cell or complete tissues was 
popularized under the term “proteomics” by Marc Wilkins at the Siena-meeting in 1994, 
when he was looking for a crisper alternative to the term “the protein complement of the 
genome”(Wilkins et al., 1996). In the early proteomics era (really the era of protein 
chemistry), even as this term had not been coined yet, chemical and enzymatic methods 
were typically used to identify highly purified proteins. Edman degradation was the method 
of choice to readout the sequence of small proteins in a stepwise manner starting from the 
N-terminus and proceeding towards the C-terminus (Edman, 1970).  However, the need of 
highly purified proteins and the limited sequencing depth of less than 50 amino acids never 
qualified this laborious work-flow for characterization of the entire protein complement of 
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biological systems. Furthermore, the traditional separation of proteins by two-dimensional 
gel electrophoresis in the proteomic field never fully delivered on its promises.  
Amongst all proteomic techniques, mass spectrometry has emerged as the method of choice 
for proteome-wide expression analysis. A prerequisite for analyzing molecules by MS is the 
ionization of the analyte as only ions can be detected by mass spectrometers. This 
requirement restricted MS for a long time to small and thermally stable compounds, 
because effective techniques for gentle ionization without immediate fragmentation were 
still to be invented. The development of soft ionization methods for intact biomolecules by 
John B. Fenn and Hillenkamp and Karas two decades ago opened the field of mass 
spectrometric analysis for complex biological samples and has became of tremendous 
success. The development of electrospray ionization was honored with the share of the 
Nobel Prize in chemistry (Fenn, 2003) .  
MS has revolutionized the field of proteomics and matured into the most important 
technology in proteomics today, because it encompasses several unique and highly desirable 
features at once. First, MS is a relatively ‘unbiased’ method and therefore well suited for 
analyzing mixtures of unknown compounds. This unbiased nature is of great advantage 
when compared to other protein detection methods like western blotting which uses 
antibodies: in that case, one can only detect what one is looking for, because of the specific 
nature of antibodies (Mann, 2008). Second, consistent with genomics, MS posseses the 
power of high-throughput and is capable of detecting thousands of peptide sequences per 
hour providing information in a global manner. Finally, modern mass spectrometers can 
deliver data of excellent quality regarding mass accuracy, sensitivity and reproducibility.  
1.4.1 Fundamentals of MS-based proteomics 
Every MS-based proteomic experiment consists of distinct steps (Figure 1-4):  
(i) Protein samples are isolated from their biological source and optionally fractionated, e.g. 
by one-dimensional gel electrophoreses (1D-PAGE). Individual bands can be excised or more 
usually the entire lane can be sliced into 14-20 parts. Proteins in the gel slices are 
proteolytically digested into peptides using different enzymes like trypsin, LysC or AspN. 
Trypsin has proven to be an especially well suited degradation enzyme because it yields 
peptides with C-terminally protonated amino acids (Arginine and Lysine), which fragment 
well in the mass spectrometer. It is also possible to digest protein mixtures in solution.  
(ii) The peptides are analyzed qualitatively or quantitatively in the mass spectrometer. 
Before peptides mixtures are sprayed into the mass spectrometer, they are separated in an 
on-line set up with the instrument. The most common method is reversed-phase (RP) liquid 
chromatography (LC), which separates peptides according to their hydrophobicity. As an 
additon to RP chromatography, strong cation exchange chromatography (SCX) can be used. 
It is also possible to combine both RP and SCX resins in series offline or in one or two 
columns to achieve even better separation. The peptide mixture, separated via nano flow 
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chromatography, is then directly electrosprayed into the mass spectrometer. The spray 
contains small droplets that contain the peptides or proteins of the sample. While entering 
the mass spectrometer the droplets become desolved while keeping the charged acquired in 
the electrospray process. The mass spectrometer analyzes the protein mixture in two stages. 
First, the survey or MS scan accurately determines the mass and signal of the peptide. In a 
second step, these peptide ions are fragmented to produce amino acid sequence related 
data (MS/MS). Subsequently, the resulting large data sets have to be analyzed by software 
tools to figure out the amino sequences, to map peptide sequences to parent proteins, and, 
if applicable, to quantify the proteins within the samples.  
 
Figure 1-4 Workflow in MS-based proteomics 
1.4.2 Mass spectrometric instrumentation and parameters 
Mass spectrometers are instruments that determine the mass of ions derived from 
molecules, in principle acting like a conventional balance. However this picture is 
oversimplified, instead the MS instruments produce gas-phase ions in the ion source, which 
are later filtered and separated according to their mass-to-charge ratio (m/z) in mass 
analyzers and finally recorded using a detector. The resulting data are mass spectra 
containing the relative abundances of ions as a function of their m/z ratios (Figure 1-4). 
Every peptide and every modification has its characteristic mass. Together with its distinct 
fragmentation pattern exact amino acid sequence and modification information can in 
principle be achieved.  Before introducing the currently most powerful mass spectrometers, 
a description of some key performance parameters is necessary.  
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Figure 1-5 Mass accuracy determination and the need for resolving power 
(i) Mass accuracy: The mass of a gas-phase ion can only be measured as accurately as the 
mass analyzers and detectors allow. Usually expressed in parts per million (ppm), the 
measurements indicates the deviation of the measurement from a known monoisotopic 
mass (Figure 1-5A). Clearly, as the mass of an analyte increases, the absolute mass error 
corresponding to a given ppm error will increase proportionally. The most powerful MS 
instrumentats in common use now have around 2-5 ppm mass accuracy, achieved by 
external calibration or internal mass standard (lock mass (Olsen et al., 2005)). 
(ii) Resolution: Resolution can be defined as the ability to “image” a detected ion in a mass 
spectrometer and differentiate it from other similar, but not identical masses. Only with high 
resolution instruments can ion peaks be visualized as isotope patterns which is of particular 
value for charge state information and accurate quantitation as illustrated in Figure 1-5B. 
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(iii) Dynamic range: The range of peptide concentrations of interest in proteomic 
measurements can vary more than six orders of magnitude. One crucial factor for the 
performance of a mass spectromter is its dynamic range, in other words, the ability to 
discern low abundance peptide peaks from the most highly abundant signals. Current mass 
spectrometers, like the LTQ-Orbitrap™ have a dynamic range or around 5000 in single scans 
for binary mixtures, which means that peaks 5000-fold less intense than a peak can still be 
detected. 
(iv) Acquisition speed: A major parameter of a mass spectrometer is the time necessary for 
acquisition of MS- and MS/MS spectra. Especially in the analysis of proteomics samples, the 
speed of the mass spectrometer determines how much information can be gained.  
(v) Sensitivity: This parameter is a value for the minimal amount of sample that can be 
detected. It is important for analyzing small numbers of cells and is limited by the need to 
trigger a recognition event at the mass detectors. 
1.4.3 Hybrid mass spectrometer: the LTQ-Orbitrap™ 
Because proteomic analyses has become more and more complex, it is of great interest to 
develop instrumentation that are able to acquire information in an accurate manner, with 
respect to mass accuracy, acquisition speed, sensitivity and resolution power. Unfortunately, 
a single kind of mass analyzer is not able to combine all these three requirements. However, 
it turned out that a combination of different mass analyzers with different characteristics in 
the same instrument enhanced performance greatly: this realization led to the concept of 
hybrid mass spectrometers. 
The introduction of the LTQ-Orbitrap™ (Hu et al., 2005) in 2005 was a major breakthrough in 
the field of MS-based proteomic instrumentation.  This hybrid mass spectrometer consists of 
a linear ion trap (LTQ) coupled to a C-trap and a novel Fourier transform mass analyzer, 
called the Orbitrap. The Orbitrap works very well as a high resolving, accurate mass detector 
with high dynamic range, whereas the LTQ is the ideal partner instrument with its exquisite 
sensitivity, very fast scanning rates and its MSn capability. One operation cycle consists of an 
accurate determination of the parent ions in the Orbitrap (full scan, MS) and consecutive 
fragmentation and detection steps of typically the five most abundant precursor ions in the 
LTQ (MS/MS). In this, the hybrid nature of the instrument is of great importance, because 
both types of scans can be done largely in parallel, which makes the Orbitrap superior in 
speed. Together with its capabilities of internal calibration, called lock mass, where 
omnipresent ions from ambient air are used to improve mass accuracy (Olsen et al., 2005), 
the LTQ-Orbitrap is the most powerful instrument for any proteomic experiment today.  
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1.4.4 Quantitative MS-based proteomics 
Mass spectrometry is widely applied to identify components in a qualitative manner. To gain 
deeper insights into biological systems there is a clear trend to study protein changes 
quantitatively. MS itself is inherently not quantitative because peptides exhibit a broad 
range of different proprieties like size, charge, hydrophobicity, etc. which alter their 
ionization capabilities and which lead to large differences in their MS responses. Therefore 
many chemical and metabolic labeling strategies have been developed to obtain the needed 
quantiative information. Basically all labeling strategies rely on stable isotope dilution 
(Jonckheere et al., 1980): stable, non-radioactive isotopes like deuterium (D), carbon13 (13C), 
nitrogen15 (15N) are introduced in one of the samples and directly compared to sample with 
the native counterpart of these isotopes. As MS can distinguish and resolve mass differences 
both samples can be analyzed together and directly quantified by comparing the labeled and 
the unlabeled peptide signals. Besides quantitation methods based on integration of stable 
isotopes, either chemically or metabolically, alternative strategies, called label-free 
quantitation methods, have emerged. These methods directly compare peptide intensities 
from different experiments.  
1.4.4.1 Isotope coded affinity tag (ICAT) 
The very first approach of using isotope coded mass tags for quantitative proteome analysis 
was developed in 1999 by Ruedi Aebersold and coworkers (Gygi et al., 1999). In pioneering 
work, they targeted cysteine residues in proteins using a thiol-specific anchor group 
combined with a biotin moiety for affinity purification. The crucial step was to connect those 
two functionalities with a mass-encoded linker group containing either zero or eight 
deuterium atoms in the light or heavy form respectively, resulting in a well-detectable mass 
shift (Figure 1-6). 
 
Figure 1-6 ICAT reagent 
In the original Isotope coded affinity tag (ICAT) experiment, two batches of proteins were 
reduced, alkylated, modified with each ICAT reagent and combined. After digestion, ICAT-
labeled peptides were enriched using avidin-affinity columns and, after elution, analyzed by 
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MS. Although the affinity enrichment decreases the complexity of the sample dramatically, 
which is undoubtfully of advantage for quantitation, this approach has some severe 
disadvantages. Some proteins may contain only a few or even no cysteines and are therefore 
excluded from accurate quantitation. The fact that only a few peptides can be quantified in 
general reduces the reliability of quantitation. In addition, the separation using RP-
chromatography is not trivial because the deuterium atoms cause a retention time shift 
compared to their light counterparts complicating correct quantitation. It should also be 
noted that the original ICAT tag generates very abundant peaks in MS/MS spectra making 
database searches more difficult. The next-generation ICAT reagents were significantly 
improved using 13C atoms instead of deuterium improving the chromatography properties or 
acid-cleavable biotin taq, however the caveats about targeting only cysteine-residues still 
remain and the ICAT method is not in general use today.  
1.4.4.2 Isobaric tags for relative and absolute quantitation (iTRAQ) 
The isobaric tag for relative and absolute quantitation (iTRAQ) method has been developed 
for quantitation of up to 4 samples (4-plex), but 8-plex implementations have also become 
commercially available. iTRAQ uses NHS (N-hydroxysuccinimide) chemistry to target all free 
N-termini and free amines in lysine side chains of peptides (Ross et al., 2004). The innovative 
concept of iTRAQ is based on a tag that generates specific reporter ions (m/z 114, 115, 116 
and 117) for quantitation in the low mass region on the MS/MS spectra level. Combined with 
a balance group, which varies also in mass, the combined masses of reporter and balance 
groups remain constant, forming isobaric peptides with indistinguishable mass at the MS 
level, which precisely co-elute in liquid chromatography separations (Figure 1-7A).   
 
Figure 1-7 iTRAQ reagent 
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With this approach peptides of samples to be compared are labeled with different sets of 
iTRAQ reagents after enzymatic digestion (Figure 1-7B) and separated via RP 
chromatography. Upon peptide fragmentation, the different mass tags also fragment giving 
rise to the reporter signals, which can be easily quantified. However, it should be noted, 
that, as the label is introduced at a late stage of the sample preparation, controlling the 
reproducibility of the measurements is challenging. 
1.4.4.3 Stable isotope labeling by amino acids in cell culture (SILAC) 
The SILAC approach is the most prominent methods for introducing heavy isotopes into 
samples by metabolically labeling (Figure 1-8). 
  
Figure 1-8 SILAC-based quantitation workflow 
In SILAC this is achieved by providing heavy isotopes to a cell culture system, so that these 
isotopes are exclusively incorporated into newly synthesized proteins (Ong et al., 2002). 
Typically, cells are grown in culture media containing either the naturally occurring form or 
the heavy stable isotope form of the amino acids lysine or arginine. Both lysine and arginine 
are labeled in different combinations of 13C, 15N and 3H in order to generate distinguishable 
mass shifts. The differentially labeled samples are combined, mixed and digested with a 
suitable protease, before being analyzed by mass spectrometry. The combination of the 
Introduction  24   
amino acids lysine and arginine together with trypsin as a digestion enzyme is especially 
advantageous because trypsin cleaves C-terminally to both amino acids, which ensures that 
that in principle all observed peptides are also quantifiable (except the C-terminal peptide of 
the protein) (Olsen et al., 2004).  
The incorporation of the mass tags happens very early, already during cell culture and prior 
to any sample fractionation, minimizing potentials biases due to separate handling of the 
samples. This makes SILAC superior to chemical labeling strategies. However, an important 
constraint is its limitation to cells growing in cell culture. 
1.4.4.4 Quantitation without stable isotopes (“label-free” quantitation) 
Stable isotope based approaches for quantitation are not always practical and might be 
relatively expensive. It should also be considered, that all these methods are limited by the 
available tags, which might not be sufficient for comparative analysis of multiple samples in 
a simultaneous way. Despite the success of isotope labeled methods, label-free quantitation 
is potentially the simplest and most economical method. It would also be ideal for certain 
types of samples such as clinical material and in vivo material. The main advantage of 
metabolic labeling is its much greater accuracy and robustness, which is mainly due to its 
tolerance towards irreproducibility in sample processing steps. Furthermore, peptide 
quantitation is performed pair wise within each MS full scan, excluding any bias between 
measurements.  
A vast literature, as well as associated methods already exists on the topic of label-free 
quantitation (see for example (Bantscheff et al., 2007; Listgarten and Emili, 2005; Mueller et 
al., 2008)). One possible estimation of protein abundance in a label-free manner is that the 
number of peptides identifying a protein scales with protein amount. Yet, the number of 
detected peptides is also dependent on the size of the protein itself. This has lead to the 
definition of the “protein abundance index” (PAI), where the number of observed peptides, 
normalized against the number of identifiable peptides for a certain protein, is regarded as a 
measure of protein abundance (Rappsilber et al., 2002). However, as the number of 
identified peptides and protein abundance in a defined sample is logarithmic, a modified 
version of PAI, called “exponentially modified PAI” (emPAI) has been introduced (Ishihama et 
al., 2005a).  
A more elegant way to quantify proteins amongst different samples would be the use of the 
extracted ion current (XIC), which is the volume under the curve generated by plotting the 
signal intensity of a peptide over the elution time. This information should be available for 
every peptide, if high mass resolution is provided.  
The comparison of subsequent MS runs is very challenging. In the absence of internal 
controls (such as exist automatically in a SILAC experiment), XIC-based quantitation is still 
regarded as inaccurate and unreliable at the current time.  
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1.5 Prologue to this thesis 
This study was conducted with two major goals in mind. The main focus was the in-depth 
characterization of dendritic cell subsets. These rare cells have great influence on our 
immune system, uniquely connecting innate and adaptive immune responses and controlling 
‘magic spots’ of the immune system. However, laborious workflows for the isolation of 
sufficient cell numbers of each subset in high purity prevented their characterization on a 
proteome level so far. A further drawback of using cells directly isolated from mice is the 
incompatibility with the SILAC approach for accurate MS-based quantitation. This issue 
directly relates to the second objective of my thesis, done in collaboration with Juergen Cox, 
namely the development of a robust, proteome-wide quantitation approach without any 
need of stable isotopes, to make it applicable for quantitative analysis of rare in vivo cells. 
The third main topic of my thesis was the extension of the SILAC approach from in vitro to in 
vivo. I was involved in the development of a stable isotope labeled mouse, which can be 
used for accurate quantitation of in vivo samples.                
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Abstract 
Dendritic cell populations consist of multiple subsets that are essential orchestrators of the 
immune system. However their functional relationships and properties are not completely 
defined. Technological limitations have so far prevented systems-wide, accurate proteome 
comparison of rare cell populations in vivo. Here we used high resolution mass 
spectrometry-based proteomics combined with newly developed label free quantitation 
algorithms to determine the proteome of mouse conventional dendritic cell subsets to a 
depth of 5,780 proteins. We found mutually exclusive expression of pattern recognition 
pathways not previously known to be subset specific. Our experiments assign key viral 
recognition functions, thought to be mainly mediated by CD8α+ dendritic cells, to be 
exclusively expressed in CD4+ and DN dendritic cells. Thus robust label free quantitation is 
feasible for proteome wide comparisons of rare in vivo cell populations and provides direct 
insight into specific functions of closely related cell types. 
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2.1 Introduction 
Dendritic cells (DCs) are a highly specialized master regulators of the immune system 
involved in responses ranging from resistance to infection to self-tolerance. Mouse spleen 
contains two major subsets of DCs, plasmacytoid DCs (pDCs) and conventional DCs (cDCs). 
cDCs can be further segregated according to different expression of surface markers into 
CD4+ cDCs, CD8α+ cDCs and CD4-CD8α- cDCs (double-negative (DN) (Shortman and Naik, 
2007; Vremec et al., 2000)). Importantly, different DC subsets appear to have specialized 
roles in immune responses (Villadangos and Schnorrer, 2007; Villadangos and Young, 2008). 
pDCs, also called natural interferon-producing cells, uniquely secrete very large amounts of 
type I interferons (IFN I) directly upon activation and therefore play an important role in 
response to viral infections (Fuchsberger et al., 2005). Amongst the cDC subsets, CD8α+ DCs 
appear to be particularly important in the context of different viral infection models (Allan et 
al., 2003; Belz et al., 2005; Belz et al., 2004). CD8α+ DCs have the ability to cross-present 
antigens, a process in which exogenous antigen is presented to T cells by MHC class I 
molecules to activate cytotoxic CD8+ T cells (Heath et al., 2004). In addition, CD8α+ DCs are 
mainly associated with a TH1 inducing profile due to their ability to secrete extremely high 
amounts of the pro-inflammatory cytokine IL-12 (Maldonado-Lopez et al., 1999). CD4+ DCs 
and DN DCs are particularly potent in stimulating CD4+ T cells via MHC II-antigen complexes. 
In contrast to CD8α+ DCs, CD4+ DCs and DN DCs are mainly involved in stimulating a TH2 
response (Maldonado-Lopez et al., 1999). 
Innate immunity largely depends on the recognition of highly conserved structures of 
pathogens that are distinct from the host, so called pathogen-associated molecular patterns 
(PAMPs) (Janeway and Medzhitov, 2002). These PAMPs comprise two broad classes of 
biochemical compounds (Beutler et al., 2006). The first category includes products of 
microorganisms such as lipopolysacchride and lipotechoic acid. The second category consists 
of nucleic acids derived from pathogens, particularly viruses. Receptors involved in 
recognition of nucleic acids from viruses activate type I interferon secretion, which places 
the host in a state of general alert (Stetson and Medzhitov, 2006). DCs express a great 
variety of pattern recognition receptors (PRRs), such as toll-like receptors (TLRs), RIG-like 
helicases (RLHs) or NOD-like receptors (NLRs) (Akira et al., 2006). Whereas the majority of 
TLRs are expressed on the cell surface, the TLRs recognizing nucleic acids namely TLR3 
(sensing double-stranded RNA [dsRNA]), TLR7 and TLR8 (sensing single-stranded RNA 
[ssRNA] and TLR9 (sensing CpG-DNA), are located in endosomal/lysosomal compartments 
within the cytosol (Alexopoulou et al., 2001; Heil et al., 2004; Hemmi et al., 2000). TLRs in 
general elicit cellular responses by recruiting several adaptor molecules such as MyD88 and 
TRIF, leading to the expression of inflammatory genes (Kawai and Akira, 2008). 
Recently it has been shown that DC subsets differ in their ability to sense viral infections. 
pDCs rely on the TLR system, namely TLR7 and TLR9, whereas cDCs mainly uses the 
cytoplasmic virus sensors retinoic-acid-inducible gene I (RIG-I) and melanoma differentiation 
antigen 5 (MDA5) (Kato et al., 2005). Several studies, using mice lacking RIG-I and MDA5, 
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reported the importance of both cytoplasmic sensors for different virus infection models in 
vivo and in vitro (Kato et al., 2008; Kato et al., 2006). On binding to their cognate ligands, 
RIG-I and MDA5 recruit adaptor molecules like Cardif (also called IPS-1, VISA or MAVS) 
(Meylan et al., 2005) that are distinct from those that mediate TLR signaling, although both 
pathways converge on interferon regulatory factors (IRFs) and NF- B for the production of 
inflammatory cytokines and interferons (Kawai and Akira, 2008).  
The molecular basis for the functional segregation of cDC subsets is still incompletely 
defined. Although microarray experiments provided first insights (Dudziak et al., 2007; 
Edwards et al., 2003a), there is no systems-wide information about differences in protein 
composition between cDC subsets. We reasoned that differences in protein abundance 
might provide us with direct insights into functional differences between cDC subsets.  
Mass spectrometry (MS)-based proteomics can identify thousands of proteins in complex 
samples (Aebersold and Mann, 2003). In addition a variety of methods are available to 
quantitatively compare changes in protein abundance at a proteomic scale (Bantscheff et al., 
2007; Ong and Mann, 2005; Panchaud et al., 2008). Most quantitative MS methods rely on 
differential labeling of protein samples with stable isotopes. These introduce a mass 
difference between differentially labeled peptides that can be differentiated by MS. Our 
laboratory developed stable isotope labeling with amino acids in cell culture (SILAC) as a 
metabolic strategy that can accurately determine protein expression ratios (Ong et al., 
2002). We showed recently that the SILAC approach can also be used to label entire mice 
(Kruger et al., 2008). Unfortunately, comparison of DC subsets in vivo would require pooling 
of cells isolated from a significant number of labeled animals and therefore be prohibitively 
expensive.  
An alternative to stable isotope labeling is ‘label-free’ quantitation. In this case, peptide 
intensities measured during individual LC runs are compared across runs (Bantscheff et al., 
2007). In general, label-free quantitation is very attractive because it can be applied to any 
proteomic sample material without need of introducing isotopes for quantitation.  However, 
label-free methods are generally much less accurate than isotope-based methods and 
proteome-wide quantitation has not yet been possible (Schiess et al., 2008; Xu et al., 2008). 
Major challenges in label free quantitation are matching of thousands of peptides across 
samples, variability in LC-MS resulting in retention time shifts and errors introduced by slight 
differences in sample fractionation steps. 
Here we studied the differences in abundance of proteins in cDCs subsets using a novel 
algorithm for label-free quantitation, which we have recently developed (Cox et al., 
submitted and attached). We here introduce this MS-based label-free quantitation approach 
to profile protein abundance differences of cDC subsets to a depth of more than 5000 
proteins requiring only 1.5 - 2.0 x106 FACS purified cells. This technology now makes it 
possible to study closely related cell types in vivo. Expression profiles show substantial 
overlap but also highly informative differences in protein composition between the three 
cDC subsets. Our analysis reveals mutually exclusive expression of pattern recognition 
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pathways not previously known to be subset specific. We show that members of the NOD-, 
TLR and RLH signaling pathways are differentially expressed in cDC subsets. Amongst these, 
RIG-I and MDA5 are significantly higher or uniquely expressed by CD4+ and DN cDCs. This 
lack of viral recognition receptors in CD8 + cDC is surprising, because CD8 + cDC are thought 
to be the main mediators of antiviral defense amongst cDC subsets. In agreement with their 
selective expression of RIG-I and MDA5, only CD4+ and DN cDC subsets, but not CD8α+ cDCs, 
were able to recognize and produce type I interferon in response to direct RNA virus 
infection. Thus label-free, proteome-wide quantitation assigns key viral recognition 
functions to CD4+ and DN cDCs. 
2.2 Experimental Procedures 
2.2.1 Mice 
All mice were bred and maintained either in the animal facility at Bavarian Nordic GmbH 
(BN) or the Max Planck Institute of Biochemistry (MPIB) according to institutional guidelines. 
Experiments were generally done between 8-12 weeks of age. Mutant mice lacking MyD88 
were generated by S. Akira (Adachi et al., 1998) and backcrossed on a C57BL/6 background 
by H. Wagner. Cardif deficient mice on a C57BL/6 background were provided by J. Tschopp 
(Meylan et al., 2005). C57BL/6 wildtype were obtained from the animal facility of MPIB. 
2.2.2 Cells, Flow Cytometric Analysis and Sorting  
cDC subsets were isolated from pooled mouse spleens from wild type, MyD88-/- and Cardif-/- 
C57BL/6 mice as described (Vremec et al., 2007). Briefly, spleens were chopped, digested 
with collagenase (Worthington Biochemical) and DNase (Roche) at room temperature, and 
treated with EDTA. Low-density cells were enriched by density centrifugation (1.077 g/cm3, 
Progen Biotechnik, adjusted to 308 mOs mouse osmolarity). Non-DC lineage cells were 
coated with mABs (anti-CD3, KT3-1.1; anti-Thy-1, T24/31.7; anti Gr-1, 1A8; anti-CD19, ID3; 
anti-erythrocytes, TER119 and anti-NK cells, DX5). pDCs were  depleted by adding anti-B220 
(RA3-6B2) in the mAb depletion cocktail. Depletion was done using anti-rat Ig magnetic 
beads (Qiagen). Dead cells were stained with propidium iodide (PI) and gated out. For 
purification and segregation of the populations of cDCs, the pre-enriched DC preparations 
were fluorescent cell sorted based on the expression of CD11c, CD45RA, CD4 and CD8α (all 
BD Biosciences) using a FACS Aria instrument (BD Biosciences).  
Activation of cDC subsets was determined by CD86 expression using a FACS Calibur 
instrument (BD Biosciences). Analysis of FACS data was performed with WEASEL software 
(The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia).  
Flt3-ligand derived dendritic cells were prepared as described (Naik et al., 2005). Briefly, 
bone marrow (BM) cells were flushed from femurs and tibiae of WT, MyD88-/- and Cardif-/- 
mice and depleted of red blood cells. Total BM cells were cultured at 1.5x106 cells/mL in 
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RPMI 1640 media supplemented with 10% fetal calf serum (FCS), 50µmol/L ß-
mercaptoethanol, antibiotics and 35ng/mL recombinant mouse (recmu) FL for 8 days at 
37°C. Recmu FL was expressed in Chinese hamster ovary cells and purified in house as 
described previously (O'Keeffe et al., 2002b). Fluorescent cell sorting into both eCD8+ and 
eCD8--cDC subsets was done based on expression of CD11c, CD11b, CD24, CD103 and CD45R 
(all BD Biosciences).  
2.2.3 Sample preparation for mass spectrometry  
FACS purified cDC subsets were washed two times in PBS and immediately frozen on dry ice. 
Cell lysates were boiled in 2x LDS-buffer, separated by 1D-SDS PAGE (4-12% Novex mini-gel, 
Invitrogen) and visualized by colloidal Coomassie staining. The gel was cut into 14 slices and 
each slice was subjected to reduction, alkylation and in-gel digestion with sequence grade 
modified trypsin (Promega) according to standard protocols (Shevchenko et al., 1996). After 
digestion peptides were extracted by 30% acetonitrile in 3% TFA, reduced in a speed vac and 
desalted using StageTips before analysis by mass spectrometry (Rappsilber et al., 2003).  
2.2.4 Mass spectrometric analysis  
All mass spectrometric (MS) experiments were performed on a nanoflow HPLC system 
(Agilent Technologies 1100 or 1200) connected to a hybrid LTQ-Orbitrap(Thermo Fisher 
Scientific, Bremen, Germany), equipped with a nanoelectrospray ion source (Proxeon 
Biosystems). Peptide mixtures were separated by reversed phase chromatography using in 
house-made C18 microcolumns (75 µm ID packed with ReproSil-Pur C18-AQ 3-µm resin, Dr. 
Maisch GmbH) with a 2h gradient from 5% to 60% acetonitrile in 0.5% acetic acid at a flow 
rate of 200nl/min and directly electrosprayed into the mass spectrometer. The LTQ-Orbitrap 
was operated in the data dependent mode with a full scan in the Orbitrap with a resolution 
R=60,000 at m/z 400 after accumulation of a target value of 1 x 106 ions. Meanwhile, the five 
most intense ions with charge states ≥ 2 were isolated (target value 5,000) and fragmented 
in the LTQ part by collisionally induced dissociation. 
2.2.5 Data processing and analysis 
The data analysis was performed with MaxQuant software (version 1.0.12.12) supported by 
Mascot as a database search engine for peptide identification as described (Cox and Mann, 
2008). Label-free quantitation algorithms were added to MaxQuant by extracting isotope 
patterns for each peptide in each run. These isotope patterns were matched to each other 
across runs using peptide identifications, the very high mass accuracy and non-linearly re-
mapped retention time. Total peptide signals within each run were normalized in order to 
make experiments comparable that were performed months apart. For label-free 
quantitation we compared the maximum number of peptides between any two samples, 
resulting in a matrix of protein ratios, calculated as the median of all ratios for common 
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peptides. We used least squares regression to solve the over-determined system of 
equations to obtain the best estimate for the protein ratios. Details of the algorithm will be 
described elsewhere (available upon request to reviewers). The proportion of kinases in the 
proteome and genome were determined using the GO term 0004672.  
2.2.6 Virus infection 
Purified Sendai virus (Cantell strain, Charles River laboratories) was used for in vitro infection 
of FACS purified DC subsets from wild type, MyD88-/- and Cardif-/-  C57BL/6 mice. 1x106 DC 
subsets per ml were infected with virus at an optimal concentration for IFN-α induction in 
cDCs in RPMI 1640 medium supplemented with 10% FCS and antibiotics in the presence of 
IL-3 and GM-CSF. Cell culture supernatants were harvested 18 hours after incubation with 
the virus and secretion of IFN-α, IFN-ß and IL-6 was measured by ELISA reagents as described 
(Hochrein et al., 2004). 
2.2.7 Data and software access notes 
Identified Peptides and Proteins will be uploaded to MAPU 2.0 (proteome.biochem.de), a 
member of ProteomeCommons. Raw MS data files will be uploaded to Tranche 
(http://www.proteomecommons.org). Source code for label-free algorithms incorporated 
into MaxQuant are available at the MaxQuant.org web site upon publication. 
2.3 Results 
2.3.1 Quantitative proteomic analysis of cDC subsets 
To identify differentially expressed proteins amongst cDC subsets we used a mass 
spectrometry based proteomics approach to quantitatively compare FACS purified cDC 
subsets of the spleen of uninfected steady-state mice. cDCs were subsequently purified from 
Collagenase and DNAse digested spleens by density centrifugation and magnetic depletion 
of non-cDC resulting in a 70-80% enriched cDC cell population, which was segregated into 
subsets according to the expression of CD8  and CD4  surface molecules using flow 
cytometry (Figure 2-1A). cDCs preparations from pooled spleens of 32 mice consistently 
yielded more than 2.5x106 cDCs per subset with purity higher than 95%, as estimated by 
FACS-reanalyses (Figure 2-1B).  
Sorted CD4+, CD8α+ and DN cDCs, resulting in 20 to 25 g total protein each, were separated 
by 1D sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and after 
tryptic in-gel digestion analyzed by LC-MS/MS (LTQ-Orbitrap). We repeated this experiment 
twice with different pools of spleens resulting in biological triplicates. 
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LC-MS/MS data from all 126 gel slices of the three independent large scale experiments 
were combined and analyzed by MaxQuant (Cox and Mann, 2008).  
 
Figure 2-1 Experimental strategy for in vivo cDC subset proteomics (A) and FACS purification (B) 
We incorporated new algorithms for label-free quantification into MaxQuant, which allows 
us to quantify peptides across individual LC-MS/MS runs (Cox et al., submitted and 
attached). Analysis of the entire dataset using uniform statistical criteria identified 1,283,676 
peptides (99,228 non-redundant sequences), corresponding to 5359, 5642 and 4830 
proteins in CD4+, CD8α+ and DN cDCs with 99% certainty, respectively.  
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Summed peptide intensity is a good proxy for absolute protein abundance (de Godoy et al., 
2008b) and by this measure we covered the cDC proteomes across more than four orders of 
magnitude. The cDC proteome of 5780 proteins shows no bias against low level regulatory 
proteins such as kinases (209 identified or 3.6% of our proteome vs. 4.2% in the genome).   
Relative label-free quantitation was highly reproducible between biological replicates and 
correlation between normalized protein intensities was between 0.84 and 0.96 (Figure 2-2). 
Hence, label free quantitative proteomics provides an accurate means of comparing 
differences in protein expression between cDC subsets in vivo for thousands of proteins. 
 
Figure 2-2 Reproducibility of biological and technical replicate measurements of (A) CD4
+
 cDCs, (B) CD8α
+
 cDCs 
and (C) DN cDCs. Correlation is determined by Pearson coefficient 
Expression levels of most proteins were similar and only a relatively small number showed 
statistically significant differences between any two subsets (p ≤ 0.01) (Figure 2-3). Overall, 
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differences in protein expression patterns showed that CD4+ and DN cDCs were more closely 
related to each other than to CD8 + cDCs (Figure 2-3) as already suggested by microarray 
analysis (Edwards et al., 2003a).  
 
Figure 2-3 Volcano plot of protein expression differences between cDC subsets as a function of statistical 
significance. Proteins with no detectable signal in one of the subsets were assigned a ratio of infinity. (A) CD4
+
 
vs. CD8α
+
 cDCs, (B) CD4
+
 vs. DN cDCs and (C) DN vs. CD8α
+
 cDCs 
We then analyzed the correlation between label-free quantitation results and known marker 
proteins of cDC subsets. All subsets expressed CD11c, the pan-marker of DCs. Markers for 
other lymphocyte lineages like CD19 for B lymphocytes, CD3 subunits for T lymphocytes or 
Nk1.1 for NK cells were not detected, indicating that sorted cDC populations were indeed 
pure and did not contain detectable contaminations from other cell types. The surface 
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markers CD4 and CD8α, which were used for FACS purification were expressed by the 
respective population and correctly assigned by our bioinformatic algorithms. Importantly, 
this was also true for other known surface markers such as DEC-205 and CD36 for CD8α+ DC, 
and CD11b, 33D1 and SIRPα for CD4+ and DN cDCs (Table 2-1). Correct assignment of these 
key surface markers by hypothesis free quantitative label free proteomics demonstrates the 
robustness of our approach. TLR3, an endosomal TLR, provided a further positive control 
(Edwards et al., 2003b) (Table S2-1 online).  
Table 2-1 Numbers are the median of summed peptide intensities in ion counts per second over three 
biological replicates. 
 CD4+ cDCs CD8 + cDCs DN cDCs 
CD11c 78,828,000 58,823,000 55,484,000 
CD8α 0 3,876,600 0 
CD205 381,840 6,461,300 443,580 
CD36 92,491 3,421,300 445,720 
CD4 1,096,000 0 0 
Sirpα 6,585,700 139,680 4,044,100 
33D1 950,990 0 694,500 
CD11b 17,304,000 1,211,600 16,806,000 
 
Subset restricted transcription factors distributed as expected; for example interferon 
regulatory factor 8 (IRF-8) was specific to CD8 + compared to  CD4+ DCs, whereas IRF-4 and 
the NF- B subunit RelB were much more abundant in CD4+ DCs (Table S2-1 online). 
Interestingly, the class I NF- B family members Nf B1 and Nf B2 have a similar expression 
pattern to RelB while RelA and c-Rel have no subtype specificity, suggesting a functional 
specialization of the NF B pathway in cDC subtypes, previously only suggested by 
differential effects on DC subsets in mutant mice lacking members of the NF- B family 
(O'Keeffe et al., 2005b; Wu et al., 1998) .  
CD97, a member of the EGF-TM7 family of adhesion receptors implicated in leukocyte 
homing, was four-fold more abundant in CD8α+ compared to CD4+ cDCs. Flow cytometry 
with antibodies against CD97 independently confirmed our proteomic finding (Figure 2-4). In 
contrast, previous microarray data did not classify CD97 as a surface molecule with 
significant higher expression on CD8α+ cDC (Dudziak et al., 2007; Edwards et al., 2003a).  
 
Figure 2-4 Expression of CD97 between cDC subsets measured by FACS 
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Proteome and transcriptome measurements do not necessarily agree, either due to 
technical factors or due to additional regulation at the protein level (Bonaldi et al., 2008).  
2.3.2 Protein expression reflects different functionality of cDC subsets 
Pattern recognition receptors endow DCs and other cells with the ability to sense pathogen 
associated molecular patterns (Akira et al., 2006) and activate defense programs upon 
encountering their cognate ligands. Differential expression of individual receptors 
determines the possible functional response of a cell to a pathogen. We reasoned that 
differences in protein abundance of individual PRRs might provide us with direct insights into 
functional differences between cDC subsets. It was previously known that certain TLRs are 
differentially expressed by cDCs (TLR7 only in CD4+ and DN cDCs; TLR3 mainly in CD8 + cDCs) 
(Table S2-1 online, (Edwards et al., 2003b). Analysis of the expression of other TLRs 
identified in our analysis revealed that the expression of two uncharacterized members of 
the TLR family, TLR12 and TLR13 are mainly restricted to CD8 + cDCs. On the other hand, 
members of the NOD-like receptors, NOD1 and IPAF, were much more highly expressed in 
CD4+ and DN cDCs (Figure 2-5). 
 
Figure 2-5 Differential expression of pattern recognition receptors between CD4+ and CD8α+ splenic cDCs. 
Members of pattern recognition receptors are color coded according to statistical significance, with red 
denoting higher expression in CD4+ cDCs with p ≤ 0.01. Likewise green denotes higher expression in CD8
DCs. Grey, filled boxes are for proteins with no statistically significant change between subsets (p > 0.01). 
Unfilled boxes with asterisk are for proteins that have been detected but not quantified, whereas proteins with 
unfilled boxes have not been detected. Numbers in parentheses are fold changes determined by label-free 
proteomics 
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CD8α+ cDCs are thought to be equipped with antiviral functions due their unique capability 
to cross-present viral antigens and their ability to produce high amounts of IL-12, which 
activates antiviral NK cells and T cells (Allan et al., 2003; Belz et al., 2005; Belz et al., 2004; 
Maldonado-Lopez et al., 1999). However, our data show a higher expression of the viral RNA 
recognition molecules RIG-I and MDA5 (Kato et al., 2008; Kato et al., 2006) in CD4+ and DN 
DCs (Figure 2-5). These RIG-like helicases (RLHs) signal through interaction with Cardif, which 
relays the signal to downstream activation of transcription factors and type I IFN response 
and proinflammatory responses (Meylan et al., 2005). Consistently, NLRX1, a potent 
regulator of Cardif, is also more highly expressed in CD4+ cDCs (Figure 2-5, Table S2-1 
online). RIG-I was described to be essential for induction of type I interferon (IFN) upon RNA 
virus infection of all cDCs (Kato et al., 2005).  However, our results suggest that not all cDC 
subsets are equally equipped to sense RNA viruses. This is further supported by the higher 
expression in CD4+ and DN DCs of OAS1 and OAS3, which are 2’,5’-oligoadenylate synthases 
(OAS) involved in antiviral defense (Silverman, 2007). The restriction of cytoplasmic viral 
recognition to CD4+ and DN cDCs does not appear to be limited to RNA viruses or RNA 
intermediates, since we also identified DAI (also known as DLM1 or ZBP1), a cytosolic PRR 
activated by dsDNA, to be more abundant in CD4+ and DN cDCs (Takaoka et al., 2007). 
2.3.3 Differential sensing of Sendai virus infection amongst DC subsets 
Next, we directly tested the hypothesis from our unbiased quantitative proteomics 
experiment that cDC subsets differ in their ability to sense viral infection by challenging 
purified cDC subsets with Sendai virus, a known activator of RIG-I (Kato et al., 2006). 
Whereas the activation-specific marker CD86  was increased in CD4+ and DN cDCs after 18h 
of viral infection, CD8α+ cDCs did not show any upregulation of CD86 (Figure 2-6A).  
 
Figure 2-6 (A) Flow cytometry histograms showing expression of CD86 of sorted WT splenic cDC subsets of after 
incubation with Sendai virus (filled histograms) or without stimulation (open histograms). (B) WT splenic cDC 
subsets were stimulated with Sendai virus and supernatants were analyzed for IFN-α by ELISA 
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We measured IFN-α production after viral infection by ELISA and found that - corresponding 
to the responsiveness seen with maturation - only CD4+ cDCs and DN cDCs produced IFN-α 
(Figure 2-6B). The production of IL-6 and IFN-ß in response to Sendai virus is also restricted 
to CD4+ and DN cDC subsets (data not shown).Thus only CD4+ and DN cDCs but not CD8α+ 
cDC respond to direct Sendai virus infection. 
In addition to RLHs, DCs can also detect viruses via TLRs. Therefore, it was possible that 
differences in virus detection were dependent upon differential TLR signaling rather than on 
the differential expression of RLHs that we detected. We ruled out this possibility with mice 
lacking MyD88 (Adachi et al., 1998), an adapter protein for most TLR signaling pathways. 
After viral infection of cDCs from these mice, both CD4+ and DN cDCs, but no CD8α+ cDCs, 
upregulated CD86 and produced IFN-α, showing that responsiveness to Sendai virus is 
functional in the absence of TLR signaling (Figure 2-7).  
 
Figure 2-7 (A) Flow cytometry histograms showing expression of CD86 of sorted MyD88
-/-
 splenic cDC subsets 
of after incubation with Sendai virus (filled histograms) or without stimulation (open histograms). (B) MyD88
-/-
 
splenic cDC subsets were stimulated with Sendai virus and supernatants were analyzed for IFN-α by ELISA 
To further verify that the RIG-I antiviral pathway is indeed the unique feature enabling CD4+ 
and DN cDCs, but not CD8 + cDCs,  to recognize direct viral infection, we tested responses of 
DCs derived from Cardif-/- mice (Michallet et al., 2008). Without Cardif none of the cDC 
subsets should be able to recognize RIG-I dependent Sendai virus infection. FL-DC bone 
marrow cultures from these mice containing equivalents of CD8α+ cDCs (eCD8+) and 
equivalents of both CD4+ and DN cDCs (eCD8-) (Naik et al., 2005) were purified by FACS and 
infected with Sendai virus. Virus infection indeed did not result in any detectable IFN-α from 
either subset of Cardif-/- mice. Furthermore, eCD8- DCs but no eCD8+ DCs of MyD88-/- mice 
were still able to produce IFN-α (Figure 2-8), showing also in the bone marrow model that 
this viral recognition is specifically dependent on the RLH pathway but not on the TLR 
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pathway. FACS purified splenic cDC subsets of Cardif-/- mice gave similar results as the cDC 
equivalents from FL-cultures (data not shown).  
 
Figure 2-8 FACS purified equivalents of bone marrow derived FL-DC from (A) MyD88 or (B) Cardif deficient mice 
were stimulated with Sendai virus, and supernatants were analyzed for IFN-α by ELISA 
Collectively, these results demonstrate that CD4+ and DN cDCs, in contrast to CD8 + cDCs, 
are uniquely equipped with the RLH pathway to sense viral infection. 
2.4 Discussion 
Multicellular organisms consist of different cell types that have specialized functions. One of 
the most striking examples of this principle is the mammalian immune system that consists 
of many different cell types with a high degree of functional diversity. As most biological 
processes are carried out by proteins, differences in protein composition should be usable to 
infer biological functions. In the context of the immune system, different cell types are 
typically characterized by FACS. While this method is very powerful to highlight differences 
in protein levels at the single cell level, it alone cannot be used to profile the cellular 
proteome in an unbiased way. Alternatively, cellular mRNA levels can provide valuable 
information, but it is generally accepted that proteins as end products of the encoded genes 
should provide more functional relevance than mRNA expression profiles. 
Here we show for the first time, that comprehensive MS-based proteomics combined with 
newly developed label-free quantitation algorithms can determine the differences in protein 
abundance for a substantial part of the proteome of steady state cDC subsets in vivo.  
To our knowledge, our dataset is the most comprehensive quantitative comparison of 
different in vivo cell populations obtained so far. We achieved reliable and reproducible 
quantitation for more than 5,000 proteins from a few microgram of FACS purified, rare cell 
types directly isolated from mice. The approach does not involve metabolic labeling and can 
thus be used to quantify in vivo protein levels in all organism including humans. No 
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additional in vitro labeling procedures are required which simplifies the procedure and 
minimizes biases introduced by differences in sample handling.  
The approach was validated by its ability to identified markers known to be expressed in a 
subset specific manner. Novel subset specific proteins were detected and validated, 
including CD97 which was not classified as differentially expressed by microarray studies 
(Dudziak et al., 2007; Edwards et al., 2003a). Collectively, our results demonstrate that label-
free quantitation can be used to directly compare levels of thousands of proteins in vivo. 
Previous functional and microarray data demonstrated selective expression of PRRs amongst 
cDC subsets. It was shown the endosomal ssRNA recognition receptor TLR7 is exclusively 
expressed in the CD4+ and DN cDC populations, corresponding with the lack of 
responsiveness of CD8 + cDCs to TLR7 ligands (Edwards et al., 2003b). Our proteomic 
analyses additionally revealed that the orphan TLRs TLR12 and TLR13 were found to be more 
abundant in CD8 + cDCs. This finding is of substantial interest since the ligands of these two 
TLRs are currently unknown, but our data indicate that, at least amongst DC subsets, their 
detection will be restricted to the response of CD8 + cDCs. The elucidation of the ligands of 
these TLRs may lend further insights into the functional capacity of CD8 + cDCs.  
Here we show that RLHs, cytoplasmic RNA detectors, and some key RLH signaling molecules 
are expressed more abundantly or even uniquely in CD4+ and DN cDCs. Only these cDC 
subsets produce Type I IFNs and IL-6 and display an activated surface phenotype upon 
infection with the ssRNA Sendai virus. This viral recognition was specific for the RLH pathway 
in these cDCs since it was functional in MyD88 mutant mice but abolished in mice lacking the 
essential RLH signaling molecule Cardif. It is tempting to speculate that the selective absence 
of ssRNA recognition molecules in the CD8 + cDCs might play an important role in the 
biology of these cells. CD8 + cDCs are well known for their crosspresentation capacity. It has 
been demonstrated that this ability is abrogated within a short time frame upon stimulation 
(Wilson et al., 2006). Lack of responsiveness to ssRNA and lack of, or at least delay in CD8 + 
cDC activation might be necessary for effective crosspresentation in ssRNA virus infection.  
Another important class of cytosolic PRRs are the inflammasome associated NLRs, which are 
involved in the activation of Caspase 1 and the secretion of proinflammatory cytokines like 
IL-1 and IL-18 (Kanneganti et al., 2007). We found higher expression of several members of 
the NLR associated molecules like NOD1, IPAF, CARD9 and CARD11 in CD4+ and DN cDCs, 
suggesting further possible functional separation amongst DC subsets. 
In conclusion, our quantitative proteome study shows the feasibility to quantify rare in vivo 
cell subpopulations at the protein level. The proteomic expression data provided direct 
insights into the functional segregation of dendritic cell subsets. Direct infection of DC 
subsets ex vivo using Sendai virus confirmed our findings. Moreover, the data produced in 
this study will provide extensive information for a future detailed comparison of the 
proteomes of mouse cDC subsets with human cDC subsets. Such a comparison would be a 
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powerful means for dissecting similarities and differences between the DCs across the 
species. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 Novel approaches for label-free quantitation 
 
Abstract 
Despite long standing interest in protein quantification without isotopic labels this 
technology has not yet developed sufficiently to allow accurate and robust proteome-wide 
quantification. We developed a new intensity normalization procedure that is fully 
compatible with any peptide or protein separation prior to LC-MS analysis. Protein 
expression profiles are assembled using the maximum possible information from peptide 
signals given that the presence of quantifiable peptides varies from sample to sample. On a 
benchmark dataset with two mixed proteomes we quantify 5,362 proteins and are able to 
detect differential regulation essentially over the entire protein expression range, with 
higher precision for abundant proteins. A t-test approach accurately describes significance of 
individual label-free quantifications. Application of these methods to liver tissue samples 
shows that technical variability of our method is much smaller than differences in expression 
patterns between individual littermate mice.  
 
 
This work is included in a manuscript under revision: 
Delayed normalization and maximal peptide ratio pairing for  
proteome-wide label-free quantification 
Jürgen Cox*, Christian A. Luber*, Nagarjuna Nagaraj and Matthias Mann 
*: These authors share first authorship 
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3.1 Introduction 
Mass spectrometry based proteomics has become an increasingly powerful technology not 
only for the identification of large numbers of proteins but also for their quantification 
(Aebersold and Mann, 2003; Bantscheff et al., 2007; Ong and Mann, 2005). In our 
laboratory, we have recently employed stable isotope labeling of amino acids in cell culture 
(SILAC) (Ong et al., 2002) for comprehensive quantification of the yeast proteome in the 
haploid vs. the diploid state(de Godoy et al., 2008a) and expression changes of several 
thousand proteins can routinely be measured in more complex eukaryotic cells (Baek et al., 
2008; Bonaldi et al., 2008; Graumann et al., 2008; Selbach et al., 2008). Thus proteomics is 
approaching the depth of other post-genomic technologies such as microarrays (Cox and 
Mann, 2007). While advances in technological development of high resolution mass 
spectrometers contributed to these developments (Makarov et al., 2006; Olsen et al., 2005), 
much of the progress can be attributed to improvements in data analysis (Cox and Mann, 
2008).  
Despite the success of isotope based methods of quantitative proteomics, label-free 
quantification is potentially the simplest and most economical method. It would also be ideal 
for certain types of samples such as clinical material. A vast literature on this topic, reviewed 
in (Bantscheff et al., 2007; Domon and Aebersold, 2006; Listgarten and Emili, 2005; Mueller 
et al., 2008), as well as associated software projects (Bellew et al., 2006; Bridges et al., 2007; 
Jaffe et al., 2006; Johansson et al., 2006; Katajamaa et al., 2006; Kohlbacher et al., 2007; 
Leptos et al., 2006; Listgarten et al., 2007; May et al., 2007; Mueller et al., 2007; Palagi et al., 
2005; Park et al., 2008; Rauch et al., 2006; Roy and Becker, 2007; Smith et al., 2002) already 
exist. However, reports thus far provide quantitative information for at most a few hundred 
proteins rather than in-depth proteome coverage. Also, while some researchers report very 
low coefficients of variation for selected quantified features, many of the reported 
biomarker proteins in the same studies are not reproducible or show much larger variability, 
questioning the robustness of these approaches. Furthermore, current label-free methods 
require measurement of the samples under uniform conditions with strict adherence to 
standard operating procedures, with minimal fractionation and in tight temporal sequence. 
The main advantage of metabolic labeling is its much greater accuracy and robustness, 
which is mainly due to insensitivity towards irreproducibility in sample processing steps. For 
instance, any upfront separation of proteins or peptides potentially poses serious problems 
in a label-free approach, since the partitioning into fractions is prone to change slightly from 
sample to sample. Chemical labeling (Gygi et al., 1999; Ross et al., 2004) is in principle 
universally applicable, but since the labels are introduced relatively late in the sample 
processing it may not be sufficiently accurate. Depending on the label used it can also be 
uneconomic in many situations.  
Two key ingredients in the excellent quantitative accuracy and depth of coverage of isotope 
based methods achieved with SILAC recently were high peptide mass accuracies and high 
identification rates. The same algorithmic steps should apply to the label-free case. 
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Increased identification rate directly improves label-free quantification because it increases 
the number of data points. While high mass accuracy aids in identification of peptides, it is 
high mass resolution which is crucial to accurate quantification. At low resolution extracted 
ion currents (XICs) of peptides are often contaminated by nearby peptide signals and robust 
deconvolution of intensities is difficult. This has led many researchers to use counts of 
identified MS/MS spectra as a proxy for the ion intensity (Ishihama et al., 2005a). However, 
XIC-based methods should clearly be superior to spectral counting given sufficient resolution 
and optimal algorithms.    
Here we solve two of the main problems of label-free protein quantification. We implement 
‘delayed normalization’ which makes label-free quantification fully compatible with any 
upfront separation.  Furthermore, we introduce a novel approach to protein quantification 
which extracts the maximum ratio information from peptide signals in arbitrary numbers of 
samples. We also select and benchmark robust statistical tests of quantification accuracy for 
each of thousands of quantified proteins.  
3.2 Experimental Procedures 
3.2.1 Benchmark dataset 
E.coli K12 strain was grown in standard LB medium, harvested, washed in PBS and lysed in 
BugBuster (Novagen) according to the manufactures protocol. HeLa S3 cells were grown in 
standard RPMI 1640 medium supplemented with glutamine, antibiotics and 10% FBS. After 
washing with PBS cells were lysed in cold modified RIPA buffer (50mM Tris-HCl (pH 7.5), 
1mM EDTA, 150mM NaCl, 1% N-octylglycoside, 0.1% sodium deoxycholate, complete 
protease inhibitor cocktail (Roche)) and incubated for 15min on ice. Lysates were cleared by 
centrifugation, and after precipitation with chloroform/methanol, proteins were 
resuspended in 6M urea/2M thiourea/ 10mM HEPES (pH 8.0). Prior to in-solution digestion 
each 60µg of HeLa S3 lysates were spiked with either 10µg or 30µg of E.coli K12 lysates 
based on protein amount (Bradford).  
Both batches containing always the same amount of HeLa S3 lysates but E.coli K12 lysates in 
1:3 ratio were reduced with dithiothreitol and alkylated with iodoacetamide. Proteins were 
digested with LysC (Wako Chemicals) for 4 hours, followed by trypsin digestion (Promega) 
overnight. Protein digestion was stopped by adding 2% trifluroacetic acid. Peptides were 
separated by isoelectric focusing(Hubner et al., 2008) into 24 fractions on a 3100 OFFGEL 
Fractionator (Agilent). Each fraction was purified with StageTips and analyzed by liquid 
chromatography combined with electrospray tandem mass spectrometry on a LTQ Orbitrap 
(Thermo Fisher) with lock mass calibration (Olsen et al., 2005). The International Protein 
Index (IPI) version 3.46 human was combined with E.coli protein sequences extracted from 
the NCBI database and used for the Mascot search. MS/MS spectra were filtered to contain 
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at most six peaks per 100 Dalton intervals. The MS/MS fragment ion tolerance was set to 0.5 
Dalton (Cox et al., 2008).   
For quantification, intensities can be determined alternatively as the full peak volume or the 
as the intensity maximum over the retention time profile, using the latter here as default. 
Likewise, MaxQuant offers a choice of the degree of uniqueness required for peptides to be 
included for quantification. While offering three alternatives in general – ‘all peptides’, ‘only 
unique peptides’, and ‘unique plus razor peptides’ (Cox and Mann, 2008)  –  we choose here 
the latter version, which is a compromise between the two competing interests of using only 
peptides that undoubtedly belong to a protein and using as many peptide signals as possible.  
3.2.2 Mouse liver samples 
Six male sibling C57BL/6 mice were sacrificed by cervical dislocation according to 
institutional guidelines. Livers were quickly excised and processed as described(Shi et al., 
2007). Livers were weighed and homogenized in 50 mM Tris buffer pH 8.0 containing 6M 
Urea/2M thio-urea. This homogenate was cleared by centrifugation and in-solution digested 
with LysC (Wako Chemicals) for 4h, followed by trypsin (Promega) overnight. Peptides were 
purified using StageTips and analyzed by LC-MS/MS as the benchmark data set. 
3.2.3 Retention time alignment and identification transfer 
To increase the number of peptides that can be used for quantification beyond those that 
have been sequenced and identified by an MS/MS database search engine, we transfer 
peptide identifications to unsequenced or unidentified peptides by matching their mass and 
retention times. A prerequisite for this is that retention times between different LCMS runs 
are made comparable by alignment. The order in which LCMS runs are aligned is determined 
by hierarchical clustering, thereby avoiding reliance on a single master run that all other 
retention times are aligned to. The bottom leaves are mostly connecting LC-MS runs of same 
or neighboring OFFGEL fractions, since they are most similar. These ‘simple cases’ are 
aligned first while moving along the tree structure increasingly dissimilar runs are integrated. 
The calibration functions that are needed to completely align LCMS runs are usually time-
dependent in a non-linear way. Every pair-wise alignment step is performed by two-
dimensional Gaussian kernel smoothing of the mass matches between the two runs. 
Following the ridge of the hill determines the recalibration function. At each tree node the 
resulting recalibration function is applied to one of the two sub-trees, while the other is left 
unaltered. The re-calibrations are accumulated for each leaf node along the way to the root.  
Unidentified LC-MS features are assigned peptide identifications by matching accurate 
masses and aligned retention times. The current high mass accuracy on FTICR and Orbitrap 
instruments is in complex proteomes still insufficient for an unequivocal peptide 
identification based on the peptide mass alone. Still, when comparing peptides in replicate 
runs – preferentially of reduced complexity samples – the information contained in peptide 
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mass and recalibrated retention time is enough to transfer identifications with a sufficiently 
low FDR. The matching procedure takes into account the upfront separation, in this case 
isoelectric focusing of peptides into 24 fractions. Identifications are only transferred into 
adjacent fractions. If, for instance, for a given peptide isotope patterns are found to match 
by mass and retention time in fractions 6, 7, 8 and 17 the matches in fraction 17 are 
discarded since they have a much higher probability of being false. The same strategy can be 
applied to any other upfront peptide or protein separation, like e.g. 1D gel. All matches with 
retention time difference below 2 minutes are accepted. 
3.2.4 Statistical analysis 
Principal component analysis (PCA) and hierarchical clustering were done with the TM4 
software (Saeed et al., 2003) on the expression matrix filtered for proteins with at least 6 
nonzero intensities and with samples brought to equal standard deviation. PCA was 
performed on mean-centered data and Euclidean distance with z-scored rows and average 
linkage was used for hierarchical clustering. ANOVA p-values were corrected for multiple 
hypothesis testing with the Benjamini-Hochberg method and were called significant with 5% 
FDR. Correlation between Gene Ontology, KEGG and Pfam domains with the ANOVA p-value 
were tested with a one sided Wilcoxon-Mann-Whitney test and called significant with 5% 
Benjamini-Hochberg FDR. Expression profiles were averaged over significant categories, z-
scored and clustered with Euclidean distance and average linkage. 
3.2.5 Data and software access notes 
The workflow for label-free quantification is completely integrated into the MaxQuant 
software (Cox and Mann, 2008). Executables as well as source code of algorithms are 
available via http://www.maxquant.org upon publication. MaxQuant runs on WindowsTM 
desktop computers and is compatible with XP and Vista. Identified Peptides and Proteins will 
be uploaded to MAPU 2.0 (proteome.biochem.de), a member of ProteomeCommons. Raw 
MS data files will be uploaded to Tranche (http://www.proteomecommons.org). 
3.3 Results 
3.3.1 Creation of a proteome-wide benchmark data set 
So far it has been difficult to assess the accuracy of label-free workflows at the proteome 
scale either because only a few test proteins were spiked in or because the magnitudes of 
the protein ratio changes were not known. In order to evaluate the coverage and accuracy of 
our quantification workflow we therefore produced a benchmark dataset by mixing entire 
and distinguishable proteomes in defined ratios. The combined trypsin-digested lysates of 
HeLa and E.coli cells were separated by isoelectric focusing into 24 fractions as described 
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(Hubner et al., 2008) and analyzed by LC-MS/MS in three replicates. This was repeated with 
the same quantity of HeLa, but a three-fold increased amount of E.coli lysate. In the resulting 
six samples all human proteins should have one to one ratios while all E.coli proteins should 
have a ratio of three to one between replicate groups. 
The data was processed with the MaxQuant algorithms recently introduced for SILAC (Cox 
and Mann, 2008), omitting the steps specific to labeling. With peptide and protein false 
discovery rates (FDR) both set to 1% this resulted in the identification of 6,689 non-
redundant proteins; 4,793 of these are human and 1,888 are E.coli proteins. The remaining 
eight protein groups (Cox and Mann, 2008) contained human as well as E.coli proteins and 
were discarded. Average absolute mass deviation over all identifications is 417 ppb. The 
resulting identification rate of all submitted MS/MS spectra is very high (55.5%). MaxQuant 
recognized a total of 736,046 quantifiable isotope patterns. Inclusion of low scoring MS/MS 
hits whose top-scoring peptide sequence had been identified with another MS/MS spectrum 
increased the number of quantifiable isotope patterns by 14% to 841,517. Transferring 
identifications by matching masses and recalibrated retention times increased quantifiable 
isotope patterns more than two-fold.  
3.3.2 A novel solution to the normalization problem 
A major disadvantage of label-free quantification is that separate processing steps 
themselves inevitably introduce differences in the fractions to be compared. In principle, 
correct normalization of each fraction could eliminate this error. However, the total peptide 
signals, necessary to perform normalization of the LC MS/MS runs of each fraction, are 
spread over several adjacent runs. Therefore we cannot sum up the peptide signals before 
we have the normalization coefficients for each fraction. Here we solve this conundrum by 
delaying normalization until after all peptide signals are added followed by global 
optimization of the normalization factors for least overall proteome variation.  
Formally, we want to determine normalization coefficients Nj which multiply all intensities in 
the jth LCMS run (j runs from 1 to 144 in our example). The normalization should be done in 
an ‘endogenous’ way purely from the obtained data and without the addition of external 
quantification standards or reliance on a fixed set of ‘housekeeping’ proteins. Directly 
adjusting the normalization coefficients Nj for each of the fractions so that the total signal is 
equalized leads to errors if the fractionation is slightly irreproducible or if the mass 
spectrometric responses in the jth run are different from average. Therefore, we wish to sum 
the peptide signals over the fractions in each sample. This, however, already requires the 
determination of the run specific normalization factors Nj . To solve this problem, we exploit 
the fact that the majority of the proteome does not change between any two conditions so 
that their average behavior can be used as a relative standard.  
After summing the peptide signals across fractions with as yet unknown Nj factors we 
determined these factors in a nonlinear optimization model, which minimizes overall 
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changes for all peptides across all samples (Figure 3-1). For this we define the total intensity 
of a peptide P in sample A, as 
, run( )( ) XICP A k k
k
I N N , 
where the index  k runs over all isotope patterns for peptide P in sample A. The quantity 
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( ) log
P A
P A B P B
I
H N
I
 
is the sum of all squared logarithmic fold changes between all samples and summed over all 
peptides (Figure 3-1).  
 
Figure 3-1 Schematic construction of the function H(N) to be minimized in order to determine the 
normalization coefficients for each LC-MS/MS run. Intensity distributions of three peptides (orange, green and 
red) over samples and fractions are indicated by the sizes of the circles. H(N) is the sum of the squared 
logarithmic changes in all samples (A,B, C…) for all peptides (P, Q, R..) 
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We minimize H(N) numerically with respect to the normalization coefficients Nj by 
Levenberg-Marquardt optimization (Press et al., 2007) in order to achieve the least possible 
amount of differential regulation for the bulk of the proteins. This procedure is compatible 
with any kind of pre-fractionation and also insensitive towards irreproducibility in 
processing.  
3.3.3 Extraction of maximum peptide ratio information 
Another principal problem in label-free quantification is the selection of the peptide signals 
that should contribute to the optimal determination of the protein signal across the samples. 
A simple solution to this problem is to add up all peptide signals for each protein and then 
compare protein ratios. However, this solution discards the individual peptide ratios and 
thus does not extract the maximum possible quantification information. Additionally, it is 
inaccurate for large ratios because it aggregates the effects of increased peptide ratios and 
increased peptide numbers, overestimating the change in protein quantity. Instead, ratios 
deriving from individual peptide signals should be averaged rather than summed up because 
the XIC ratios for each peptide are already a measurement of the protein ratio.  
If all peptides identifying a protein are detected in each of the samples, then protein ratio 
determination is trivial. However, in practice peptides are often missing in specific samples. 
One way to nevertheless obtain a signal for each peptide in every sample is to integrate the 
missing peptide intensities over the mass retention time plane using the integration 
boundaries from the samples where the peptide has been identified. This procedure has the 
disadvantage that the noise level effectively substitutes for the signal, underestimating the 
true ratio (likewise setting these signals to zero will overestimate the ratio). Yet another 
possibility is to restrict quantification to peptides that have a signal in all samples. While this 
works well when comparing two samples, it becomes impractical when the number of 
samples is large: for example requiring a peptide signal to be present in all of 100 patient 
samples would likely eliminate nearly all peptides from quantification.  
We propose a novel method for protein quantification that does not suffer from the 
problems described above (Figure 3-2). We want to use only common peptides for pair-wise 
ratio determination without losing scalability for large number of samples. This is achieved 
for each protein by first calculating its ratio between any two samples using only peptide 
species (Figure 3-2A, B) which are present in both. Then the pair-wise protein ratio is 
calculated as follows, taking the pariwise ratio of the protein in sample B and C in the figure 
as an example:  First the intensities of peptides occurring in both samples are employed to 
calculated peptide ratios. In this case peptide species P2, P3 and P6 are shared (Figure 3-2C). 
The pairwise protein ratio rCB (Fig. 2 d) is then defined as the median of the peptide ratios to 
protect against outliers. We then proceed to determine all pairwise protein ratios; these 
values grow quadratically with the number of samples. For a valid protein ratio we require a 
minimal number of peptide ratios. At least two peptide ratios were required in the example 
in Figure 3-2D. 
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At this point we have constructed a triangular matrix containing all the pairwise protein 
ratios between any two samples, which is the maximal possible quantification information. 
This matrix corresponds to an over-determined system of equations for the underlying 
protein abundance profile (IA, IB, IC …) across the samples (Figure 3-2E). We perform a least-
squares regression analysis to reconstruct the abundance profile optimally satisfying the 
individual protein ratios in the matrix (Figure 3-2E, F). Finally, this procedure is repeated for 
all proteins, resulting in an accurate relative abundance estimate for each protein in each 
sample.  
 
Figure 3-2 Algorithm constructing protein intensity profiles for one protein from its peptide signals. (A) An 
exemplary protein sequence. Peptides with an XIC-based quantification are indicated in magenta. (B) The five 
peptide sequences give rise to seven peptide species. For this purpose, a peptide species is a distinct 
combination of peptide sequence, modification state and charge, each of which has its own occurrence pattern 
over the different samples (C) Occurrence matrix of peptide species in the six samples. (D) Matrix of pairwise 
sample protein ratios calculated from the peptide XIC ratios. Valid/invalid ratios are colored in green/red. If a 
sample has no valid ratio with any other sample – like sample F – the intensity will be set to zero. (E) System of 
equations that needs to be solved for the protein abundance profile. (F) The resulting protein abundance 
profile for one protein 
3.3.4 Quantification results for the benchmark set 
To apply the algorithms to the E.coli and HeLa cell mixture, we required a protein to have 
non-zero intensity in at least three out of the six samples, which is the case for 5,326 
proteins in total; 3,701 of human and 1,661 of E.coli origin (Figure 3-3A). Ratios are plotted 
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in Figure 3-3B against the summed peptide intensity, which is a good proxy for the protein 
abundance (de Godoy et al., 2008a). The human and E.coli protein populations are well 
separated, having very little overlap even at low signal intensity. For highly abundant 
proteins a fold change far below two can be distinguished from the cloud of 1:1 proteins. 
Proteins with quantitative changes are separated from non-changing proteins in 94.4 % of 
the cases (Figure 3-3C), and the remaining proteins are almost never statistically significant 
by t-test (see below). This result also indicates the robustness of our workflow because one 
of the 144 LC MS/MS runs failed, but this did not erroneously appear as a regulation of part 
of the proteome.  
 
Figure 3-3 Quantification results on the benchmark dataset. (A) Overview of identified and quantified proteins 
and peptides. (B) Logarithmic plot of protein ratio vs. summed peptide intensity for human (red) and E.coli 
(green) proteins. The vertical lines indicate the quartiles of the intensity distribution. (C) Three dimensional 
kernel density visualizing almost complete separation of quantified proteomes. For this comparison, the E.coli 
distribution (green) was scaled to the HeLa population (red) 
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How accurate are the label-free protein ratios? To answer this question we divided the 
intensity distribution into quantiles and determined the 3-σ width of the human proteins in 
each of them. In the top 25% distribution quantification was accurate within 1.64 fold, in the 
top 50% intensities 2.01 fold changes could be distinguished with statistical confidence 
whereas this value was 2.16 for the top 75%. As expected, quantification was less accurate 
for the low abundance proteins and in the lowest abundance quarter of the proteome the 
three fold change of the proteomes was marginally sufficient to clearly separate the 
distributions (3σ fold change = 3.27).   
The above analysis on a population level does not provide a statistically sound estimate of 
the probability that individual proteins are regulated. In fact, Figure 3-3B shows several 
human proteins that appear to be changing several fold and without further analysis these 
might have been mistaken as biomarkers in a clinical context. We therefore explored 
different strategies to retrieve significantly changing proteins based either on simple fold 
change or on the variance of their quantitative signal: taking the ones with highest apparent 
fold change (highest ratio of average intensities), with best Wilcoxon-Mann-Whitney p-
value, with best standard t-test p-value, and finally with best Welch modified t-test p value. 
Since we have full knowledge about which proteins are changing (only the E.coli ones) we 
independently know the real false discovery rates and can construct precision-recall curves 
for each case to assess the performance of our entire quantitative workflow. In Figure 3-4A 
the resulting four precision-recall curves are shown. Retrieving proteins by ratio 
(corresponding to a fixed fold change cut-off) is the worst strategy. It has low precision even 
at small recall values, due to the sensitivity to outlier ratios. When sorting proteins by ratios 
already the fourth protein is a false positive (Figure 3-4B).  
 
Figure 3-4 Statistical significance of protein regulation. (A) Precision-recall curves based on four different 
strategies. TP true positives; FP false positives; FN false negatives. (B) The Welch modified t-test p value is 
plotted logarithmically against the ratio. The vast majority of E.coli proteins (green) have p-values better than 
0.05 indicating significant regulation. An extremely small number of human proteins (red) appear to have a 
large ratio and significant p-value (false positives for quantitation). The arrows indicate that the best strategy is 
to select significantly regulated proteins by t-test p-value (first false positive after hundreds of correct hits with 
better p-values; blue arrow) rather than fold change (first false positive after three correct hits with higher fold 
change; magenta arrow) 
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The Wilcoxon-Mann-Whitney test performs better but has also problems at low recall. Both 
versions of the t-test perform significantly better and the Welch modified t-test is slightly 
better than the standard t-test. At a precision of 0.98 – i.e. 2% false discovery rate (FDR) – 
72% of the E.coli proteins are recalled. With a FDR of 5% which is often used in similar 
circumstances almost all (88%) E.coli proteins are retrieved with the (Welch modified) t-test.  
Finally, we compared the quantification accuracy of our label-free workflow with the SILAC-
based procedure normally used in our laboratory. Since we cannot perform a direct SILAC 
comparison of two entirely different proteomes such as E.coli and human, we selected a 
HeLa SILAC data set also obtained from triplicate analysis of 24 isoelectric focusing fractions. 
We compared the ratio distributions of the SILAC experiment against the HeLa proteins from 
this experiment (Figure 3-5). While the quantification accuracy is quite high throughout the 
proteome for label-free quantification as already described above, the accuracy of the SILAC-
based quantification in an experiment of comparable scale and proteome depth the 
accuracy is considerably higher, by a factor of 4-5 on average. This was expected since label-
based quantification allows direct quantitative determination of the peptide ratio within 
each spectrum and should therefore lead to the best possible accuracy. 
 
Figure 3-5 Comparison of ratio precision between label free and SILAC data. The points corresponding to 
human proteins are copied from Figure 3-3B (red). SILAC data (green) is from a comparable dataset on HeLa 
cells 
3.3.5 Label-free expression proteomics of mouse liver 
In order to test the performance of our label-free workflow in a typical gene expression 
context, we dissected the livers from a litter of six genetically identical male mice. In three 
replicate LC MS/MS runs we identified 2,515 non-redundant proteins at 1% FDR and 
quantified 1,866 with nonzero intensity in at least three of the 18 samples. Principal 
component analysis on the full data matrix reveals that in the first two principal components 
– which together capture 89.9% of the total variance – the difference within technical 
replicate groups is much smaller than the difference between individual mice (Figure 3-6A). 
Hierarchical clustering of the entire expression matrix also results in a perfect grouping of 
technical replicates. ANOVA reveals that more than one third (637) of the proteins show 
statistically significant inter-mouse variation compared to technical intra-mouse variability. 
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The two-dimensionally clustered expression matrix of those proteins reveals a grouping into 
three pairs of similar mice (Figure 3-6B). Their averaged expression profiles were clustered 
showing the biological processes that are distinguishable between the mice (Figure 3-6C). 
These turn out to only be metabolic functions, which is consistent with the fact that the mice 
were genetically identical and treated identically.  
 
Figure 3-6 Expression proteomics of six mouse liver samples. (A) First two principal components of the mouse 
liver samples correctly group technical replicates together and different mice apart. (B) Clustered expression 
matrix of the mouse liver samples on proteins significant in ANOVA likewise correctly clusters the mice. (C) 
Gene Ontology terms, KEGG pathways and Pfam domains enriched in significant ANOVA proteins together with 
their clustered averaged expression profiles 
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3.4 Conclusion and Perspectives 
Here we introduced two novel algorithms for quantification without stable isotopes. 
‘Delayed normalization’ efficiently solves the problem of how to compare sample fractions 
that have been purified in slightly different ways and analyzed with different MS 
performance. Importantly, delayed normalization does not require selection of arbitrary sets 
of ‘household’ genes, which are thought to be unchanging in the experiment. This is in 
contrast to mRNA measurements, were selection of normalization standards can be a 
serious experimental design issue. If desired our algorithm can nevertheless be expanded to 
perform delayed normalization only on selected groups of proteins, i.e. in cases where very 
wide-spread proteome changes are expected.  
The second algorithm allows retrieval of the maximum possible information from peptide 
ratios across samples, without resorting to arbitrary assignment of the signal when the 
peptide cannot be detected. The protein ratio is determined as the best estimate satisfying 
all the pair-wise sample comparisons.  
These algorithms performed very well in a mixed proteome experiment, which also allowed 
us to select the best performing statistical assessment of the significance of protein ratios. 
Interestingly, for label-free quantification the commonly employed fold change cut-off 
performs poorly with many proteins appearing to be regulated when they in fact are 
unchanging. The t-test, in contrast, performed excellently in both precision and recall and 
should therefore be a suitable tool for biomarker discovery studies.  
Among other advantages, our workflow allows label-free comparison of samples measured 
at separate times. Our laboratory has used this property to measure rare immunological cell 
populations over the course of more than a year, still leading to accurate quantification as 
assessed by the correct distribution of cell specific markers and by novel results that turned 
out to be functionally meaningful (Luber et al., submitted).  
What will the likely scope of label-free quantification be? As we show here, it is not as 
accurate as metabolic labeling techniques. However, it should already become the method 
of choice if isotope labeling is not possible and or if relatively large changes are anticipated. 
In future, instrumental advances will in effect elevate the majority of the proteome into the 
accuracy range now typical of the most abundant proteins. In conclusion, we predict an 
essential role for label-free quantification not only in clinical but also in other areas of 
proteomics. 
 
 
 
 
4 The SILAC mouse 
 
Abstract 
Stable isotope labeling by amino acids in cell culture (SILAC) has become a versatile tool for 
quantitative, mass spectrometry (MS)-based proteomics. Here we completely label mice 
with a diet containing either the natural or the 13C6-substituted version of lysine. Mice were 
labeled over four generations with the heavy diet without affecting development, growth or 
behavior. MS analysis of incorporation levels allowed determining incorporation rates of 
proteins from blood cells and organs. The F2 generation was completely labeled in all organs 
tested. SILAC analysis from various organs lacking expression of β1 integrin, β-Parvin or the 
integrin tail binding protein Kindlin-3 confirmed their absence and disclosed a structural 
defect of the red blood cell membrane skeleton in Kindlin-3-deficient erythrocytes. The 
SILAC-mouse approach is a versatile tool to quantitatively compare proteomes from 
knockout mice and thereby determine protein functions under complex in vivo conditions. 
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4.1 Introduction 
The administration of radioactive or stable isotope tracers to animals is a well established 
technique to investigate the rate of protein synthesis and protein degradation (Wolfe and 
Chinkes, 2005). This technology has been used for many decades (Schoenheimer and 
Rittenberg, 1935). The infusion of stable isotopes (13C or 15N) as tracer combined with 
measurements of 13CO2 or 
15N in urinary urea or ammonia is a broadly used technique to 
explore the amino acid flux in metabolic pathways (Bier, 1997; Dietz et al., 1982). Extensive 
incorporation of 13C or 15N stable isotopes does not result in discernable health effects of the 
treated animals (Doherty and Beynon, 2006; Gregg et al., 1973). 
Mass spectrometry (MS) is not inherently quantitative and relative protein expression 
changes are instead most accurately measured by comparison of the natural form of a 
peptide with its stable isotope analog (Ong and Mann, 2005). In recent years, 15N labeling 
has been applied to microorganisms such as yeast (Oda et al., 1999; Pratt et al., 2002), C. 
elegans and Drosophila (Krijgsveld et al., 2003). Even a rat has been partially (Wu et al., 
2004) or completely 15N labeled (McClatchy et al., 2007). In addition, non-saturated labeling 
of a chicken, using the essential amino acid valine, allows the MS-based analysis of protein 
turnover rates in vivo (Doherty et al., 2005). 
Our laboratory has previously described the stable isotope labeling by amino acids in cell 
culture (SILAC) (Mann, 2006; Ong et al., 2002), which has unique advantages for quantitative 
and functional proteomics because of its inherent accuracy of quantitation and the ease of 
interpretation of MS results (Blagoev et al., 2004; Kratchmarova et al., 2005). In a SILAC 
experiment two cell populations are generated, one in a medium that contains the natural 
amino acid (i.e. 12C6-lysine) and the other in a medium that contains the heavy isotope 
substituted version (i.e. 13C6-lysine). This allows direct comparison of protein expression 
levels by mixing the non-labeled ‘light’ and labeled ‘heavy’ cell populations (Cox and Mann, 
2007). Each peptide appears as a pair in MS analysis with a difference in mass of 6 Da and 
the relative peak intensities reflect the abundance ratios. To date SILAC-labeling has been 
limited to cell culture or microorganisms. To extent this powerful technique to higher 
organisms, Oda and co-workers have SILAC labeled the Neuro 2A cell line to serve as internal 
standard for quantitation of a subset of peptides of the mouse brain proteome (Ishihama et 
al., 2005b). 
In the present paper we report the development of a mouse SILAC diet that leads to 
complete labeling of the F2 generation. We used in vivo SILAC quantitation to analyze newly 
synthesized proteins from plasma and tissue samples in vivo. Furthermore, we validated our 
in vivo quantitation system by comparing the proteomes from platelets, heart and 
erythrocytes from β1 integrin, β-parvin and Kindlin-3-deficient mice, respectively. 
Integrins are heterodimeric transmembrane proteins, consist of α and β subunits, are 
ubiquitously expressed and perform cell-cell and cell-matrix adhesion functions. Association 
of the corresponding α and β subunits is required for their stability and transport to the 
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plasma membrane, as single subunits are not stable and are rapidly degraded. Integrin-
mediated cell adhesion triggers intracellular signaling pathways (outside-in signaling) that 
control migration, proliferation, survival and differentiation of cells. Prior to ligand binding 
integrins require an energy-dependent activation step, which is triggered within the cell 
(inside-out signaling) and characterized by a profound conformational change in both 
integrin subunits. Although the mechanism(s) underlying integrin activation are far from 
understood it is believed that the binding of the FERM domain-containing adaptor proteins, 
talin and Kindlin to the integrin β cytoplasmic domains represents the last step in the 
activation pathway (Calderwood, 2004; Moser et al., 2008)  
Upon activation and ligand binding integrins recruit and assemble a multiprotein complex at 
the site of cell adhesion that fulfils two major tasks: it connects the ECM with the actin 
cytoskeleton and it alters the fluxes of many intracellular signalling pathways. A preformed 
complex consisting of the three proteins, ILK, PINCH and Parvin, represents an important 
component of the integrin adhesion complex (Legate et al., 2006). Parvins are a family of 
three proteins, α-, β- and γ-parvin, that directly bind to ILK, F-actin and other actin 
associated proteins thereby linking the adhesion complex to the actin cytoskeleton and 
controlling actin dynamics. 
Kindlins have recently been identified within the integrin mediated cell adhesion complex 
and represent a further family of ILK binding proteins (Montanez et al., 2007). They consist 
of three members (Kindlin1-3) and are named after the gene mutated in Kindler syndrome, 
an autosomal recessive skin blister disease in humans. Kindlin-3 expression is restricted to 
hematopoietic cells with highest levels in megakaryocytes (Ussar et al., 2006). Inactivation of 
the Kindlin-3 gene in mice results in severe anaemia, which is thought to be due to a 
bleeding defect caused by impaired activation of platelet integrins, defects in platelet 
aggregation and thrombus formation (Moser et al., 2008).  
To screen for potential defects in other cellular compartments of the hematopoietic system 
in Kindlin-3-defcient mice we compared their proteome with those from control mice. In the 
course of these studies, we discovered a deficit of structural proteins in the plasma 
membrane of Kindlin-3-deficient erythrocytes, which contributes to the severe anaemia 
seen in Kindlin-3-deficient mice. 
4.2 Experimental Procedures 
4.2.1 Materials and reagents 
13C6-Lysine (98 atom % 
13C) was from Silantes, Martinsried, Germany. Chemicals for the ‘in 
solution’ and ‘in gel’ digests were purchased from Sigma-Aldrich, LysC was obtained from 
WAKO. Wild-type mice were obtained from an in house C57Bl/6 colony.    
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4.2.2 Knockout mice 
Transgenic mice expressing the Cre recombinase under the control of the Mx1 promotor 
(Kuhn et al., 1995) were mated with mice carrying a floxed β1 integrin gene (Brakebusch et 
al., 2000). To ensure extensive down regulation of the β1 integrin on platelets pI:pC 
(Amersham) injected intraperitoneally 3 times in a 2-day interval with  a concentration of 
250µg pI:pC per mouse. 
Kindlin-3 deficient mice were generated as described in (Moser et al., 2008). A detailed 
description of the β-parvin gene inactivation will be published elsewhere (Thievessen and 
Fässler). 
4.2.3 Food preparation, weight gain, and food consumption 
A customized lysine free mouse diet (Harlan-Tekland, TD.99386) was combined with the 
heavy L-13C6-lysine and the natural isotope L-lysine (Sigma) to a final concentration of 1%. To 
obtain a homogenous distribution of the amino acid, the powder was vigorously mixed with 
a blender for 5 min. For the preparation of food pellets, approximately 10g of the mixture 
were filled into an in-house manufactured cylinder with an inner diameter of 1.5 cm and 
length of 10 cm. Food was compressed with an exactly fitting pestle for 1 min. Pellets were 
taken out and dried over night at room temperature. After drying, the pellets were cut into 
smaller pieces. 
The lysine content was checked as described (Moore et al., 1958). Although the hydrolysis 
with subsequent chromatography does not allow exact determination of the amino acid 
contents, the supplemented lysine amount was comparable to that in the customized diet 
containing the natural lysine isotope.  
For testing weight gain and food consumption one group (n= 3 females) was fed with a 
regular mouse diet, one group (n=3 females) was fed with the customized lysine free diet 
supplemented with natural lysine (Sigma), and one animal with the diet containing the heavy 
isotope for lysine. All animals were fed ad libitum with access to water.  
Food consumption was measured daily for 10 days during breeding and weaning periods. 
Label percentage was calculated as the mean of heavy labeled peptide signal divided by the 
sum of light and heavy signal. 
4.2.4 Sample preparation 
Blood samples; mice were anesthetized with isofluran and 20 µl blood was taken from the 
retro-orbitral plexus. Blood samples were incubated with heparin (20 U/ml) and after 
centrifugation the supernatant was frozen in liquid nitrogen and stored at -80°C. Tissue 
harvest; after sacrificing animals by cervical dislocation, tissues were dissected, washed in 
phosphate buffered saline (PBS; pH 7.4), and frozen in liquid nitrogen. For protein isolation, 
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tissues were homogenized in a buffer containing 1% NP-40, 0.1% sodium deoxycholate, 150 
mM NaCl, 1 mM EDTA, 50 mM Tris pH 7.5 and protease inhibitors (Complete tablets, 
Roche).The lysates were centrifuged at 14,000 x g to pellet cellular debris. A Bradford assay 
was performed to determine protein concentrations of the supernatants.  
Mitochondria isolation; liver tissue was quickly washed in water, then three times in 250 mM 
sucrose, 10 mM Tris-HCl, 0.1 mM EGTA (pH 7.4) supplemented with protease inhibitors 
(Roche). Crude mitochondria were isolated as described previously (Forner et al., 2006) and 
purified on a 30% Percoll density centrifugation gradient. 
Platelets were isolated by differential centrifugations steps as described in (Moebius et al., 
2005). Epithelial cell isolation from gut; small intestine was cut open and washed with PBS. 
The small intestine was transferred to dissociation buffer (130mM NaCl, 10mM EDTA, 10mM 
Hepes pH 7.4, 10% FCS and 1mM DTT) and incubated for 45 minutes on a rotor at 37°C. The 
rest of the intestine was removed and the epithelial clumps were collected by centrifugation 
at 800 rpm for 5’ and PBS washed. 
For B cell isolation spleen was cut into small fragments and digested with collagenase and 
DNase followed by the addition of EDTA. Subsequently, cells were incubated with anti-
CD45R, anti-CD3, and anti-CD49b (BD PharMingen). B cells were selected as cells that 
stained positive for CD45R (B220, (Coffman, 1982)) and negative for both anti-CD3 and anti-
CD49b and then sorted using a FACS Aria system (Becton Dickinson). 
4.2.5 Mass spectrometry 
For protein separation samples were load on a NuPAGE 4%-12% Bis-Tris gel (Invitrogen). 
After staining of the gel with the Colloidal Blue Staining Kit (Invitrogen) evenly sized gel 
pieces were excised from the gel and processed for enhanced liquid chromatography-mass 
spectrometry (GeLC-MS).  
For blood analysis, Coomassie stained gel lanes were cut into eight pieces. To determine 
incorporation ratios we analyzed three gel pieces per lane from heart, gut epithelia, liver, 
red blood, and platelets samples  
The gel pieces were subjected to in gel reduction and alkylation, followed by LysC digestion 
as previously described (Andersen et al., 2005; Shevchenko et al., 1996). Finally, peptides 
were extracted twice by adding an equal volume of 30% acetonitrile/0.3% trifluoraceticacid 
(TFA) in water to digest the mixture followed by a final extraction with 100% acetonitrile. 
Extracts were evaporated in a speedvac to remove acetonitrile and subsequently acidified 
with 0.5% TFA. Samples were desalted and concentrated with StageTips and resuspended in 
5 µl of 0.5% acetic acid/ 1% TFA (Rappsilber et al., 2003). In solution digestion of proteins 
were performed as described in (Ong and Mann, 2006).     
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Reverse phase nano-LC-MS/MS was done using an Agilent 1100/1200 nanoflow LC system 
(Agilent technologies) using a cooled thermostated 96-well autosampler. The LC system was 
coupled to a 7-Tesla LTQ-FT or LTQ Orbitrap instrument (Thermo Fisher Scientific) equipped 
with a nanoeletrospray source (Proxeon). Chromatographic separation of peptides was 
performed in a 10 cm long 8 µm tip opening/75 µm inner diameter capillary needle 
(Proxeon). The column was custom-made with methanol slurry of reverse-phase ReproSil-
Pur C18-AQ 3-µm resin (Dr. Maisch GmbH). The LysC digested peptide mixtures were 
autosampled at a flowrate of 0.5 µl /min and then eluted with a linear gradient at a flow rate 
0.25 µl / min. The mass spectrometers were operated in the data-dependent mode to 
automatically measure MS and MS/MS. LTQ-FT full scan MS spectra (from m/z 300 to 1,600) 
were acquired with a resolution R = 100,000 at m/z 400 (after accumulation to a target value 
of 3,000,000 in the linear ion trap). The five most intense ions were sequentially isolated and 
fragmented in the linear ion trap using collisionally induced dissociation at a target value of 
10,000  (Olsen et al., 2004).   
Raw data files were converted to Mascot generic format files with in house software 
(Raw2MSM) and Mascot (version 2.0) was used for database search and protein 
identification. The following search parameters were used in all MASCOT searches: LysC 
digest, no missed cleavage, carbamidomethylation of cysteine was set as a fixed 
modification and oxidation of methionines, and L-lysine-6 were allowed as variable 
modifications. The maximum allowed mass deviation for MS scans was 10 ppm and 0.5 Da 
for MS/MS scans, respectively. Only proteins that had at least two peptides with ion scores 
>20 were considered for identification and quantitation. MSQuant (Schulze and Mann, 2004) 
was used to verify and quantify the resulting SILAC-peptide pairs. All proteomic results were 
deposited in the publicly accessible MAPU database (Zhang et al., 2007). A target decoy 
database approach was used to identify false positive peptides and to set threshold criteria 
such that < 1% false positives were included in the peptide list. After mass recalibration 
using MSQuant, the average absolute mass error of all peptides was better than three ppm.  
Samples from all mouse mutants were analyzed by the in house developed software 
MaxQuant (Cox and Mann, 2007; Graumann et al., 2007). Briefly, MaxQuant performs a peak 
list, SILAC- and XIC-based quantitation, false positive rates (Gingras et al., 2007), and  
peptide identification based on Mascot search results. All data were searched against the 
Mouse International Protein Index protein sequence database (IPI, version 3.24) (Kersey et 
al., 2004). Fold-change for ghost proteins was determined from the gel slice corresponding 
to the expected migration of the full length protein. 
4.2.6 Blood cell analyses 
Hematocrit was measured from peripheral blood with a hematology analyzer (Nihon 
Kohden).For “ghost” preparation, erythrocytes were washed twice in 0.9% NaCl, 10mM 
sodium phosphate buffer, pH7.0 before hypotonic lysis were performed in 0,25% NaCl, 
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10mM sodium phosphate buffer, ph7.0. Lysis was performed in several rounds in hypotonic 
buffer until the pellet became white.  
4.2.7 Flow cytometry 
Flow cytometric lacZ staining of hematopoietic cells were performed on Ter119 positive 
bone marrow cells that have been incubated with the fluorescent β-galactosidase substrate 
FDG (fluorescein di-β-D-galactopyranoside) (Sigma) as described (Montanez et al., 2007). 
Flow cytometry was carried out on a Becton Dickinson FACSCalibur. 
4.3 Results 
4.3.1 Heavy SILAC-diet has no influence on weight gain and fertility  
We prepared a SILAC diet by mixing 13C6-lysine or 
12C6-lysine into a customized lysine-free 
mouse diet to a final concentration of 1% (Figure 4-1A) according to standard mouse 
nutritional requirements (Benevenga et al., 1995). The amino acid content was subsequently 
checked by hydrolysis and cation exchange chromatography (Figure S1 online). We first 
tested whether the diet permits normal weight gain by feeding mice with a regular or the 
SILAC diet (with 12C6-lysine or 
13C6-lysine). During an observation period of four weeks all 
animals showed the same food consumption and a similar increase in body weight of about 
17% (Figure S2A,B online), normal fertility and motor activity irrespective of the diet 
consumed. Furthermore, we SILAC-labeled mice over four generations (see below), 
indicating that the labeling is compatible with normal development and physiology. Thus we 
conclude that SILAC-labeling with a 13C6-substituted essential amino acid does not lead to 
obvious discernable health effects in mice (Figure 4-1B).  
4.3.2 SILAC incorporation rates differ in blood, liver and gut epithelium 
To track 13C6-lysine incorporation into the proteome over time, we sampled blood each week 
for four weeks. Serum proteins were separated on 1D gels in triplicate, in-gel digested and 
analyzed by high resolution MS. The average relative standard deviation of all quantified 
proteins was about 20% (Figure 4-1C), an accuracy similar to previous SILAC quantitation 
experiments (Blagoev et al., 2004; Ong et al., 2003).  
As an example of different incorporation levels, SILAC peptide pairs of three serum proteins 
and one red blood cell protein are shown in Figure 4-1C. For serum albumin we observed a 
SILAC-ratio of 1:3.2 indicating that at least 74% of the protein had been newly synthesized 
during the first week of feeding. Because proteins can be synthesized from dietary amino 
acids as well as from amino acids derived by protein catabolism, this value is a lower limit for 
the true turnover (Beynon and Pratt, 2005). After four weeks the three serum proteins were 
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labeled to 90%. In contrast, hemoglobin was only labeled to 57% after four weeks (Figure 
4-1C), due to the 60 days half-life of mouse erythrocytes (Berlin et al., 1959).  
 
Figure 4-1 SILAC labeling and incorporation rates of blood proteins. (A) Mice are SILAC labeled by feeding a 
pelleted lysine-free diet supplemented with normal or heavy lysine. (B) Mice on a SILAC diet cannot be visually 
distinguished from mice with anormal, commercial diet. (C) Mass spectra showing SILAC pairs of a 
representative peptide for four blood proteins. The right hand side shows lysine-6 incorporation over four 
weeks as average measurement of triplicates 
Next, we measured the labeling efficiencies of a number of organs after four weeks of 
feeding with the SILAC diet. Proteins from heart showed an average protein ratio of 4.4 
(Figure 4-2A, Table S2 online), much lower than the serum proteins. Furthermore, the 
distribution of SILAC-ratios was relatively broad, reflecting the different incorporation rates 
of individual cell types and the ‘contamination’ of serum proteins in non-perfused samples. 
For example, serum albumin has a similarly high incorporation rate in blood (ratio 9) and 
heart (ratio 10; Figure 4-1C and Figure 4-2A). In contrast to heart tissue, in which most cells 
are quiescent, the intestinal epithelium regenerates within a few days (Radtke and Clevers, 
2005). Disaggregating the epithelium from the digestive tube resulted in a more 
homogeneous cell pool consisting of only a few cell types.  As a consequence we observed a 
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high SILAC-ratio of 9.1+/- 2.1 reflecting a labeling efficiency of more than 90 % (Figure 4-2B), 
which is fully consistent with the high proliferation rate of this tissue. For example, villin-1, a 
marker for epithelial cells from the digestive system, showed a SILAC ratio of 10. 
 
Figure 4-2 SILAC label incorporation into different cell types and tissues after 4 weeks. The panels show the 
relative number of proteins with the specified ratios for each proteome investigated. (A) heart tissue, (B) gut 
epithelium, (C) incorporation into whole liver (grey bars) is compared with incorporation into liver 
mitochondria (black bars), (D) platelets, (E) erythrocytes, (F) CD45R-positive B-lymphocytes from spleen 
Liver has a number of different physiological roles, including metabolic functions and the 
production of major blood proteins. Accordingly we observed a wide distribution of SILAC 
incorporation ratios among liver proteins. Hepatocytes are the predominant liver cell type, 
and they are very rich in mitochondria. To demonstrate that in vivo SILAC ratios can be 
measured with subcellular resolution we isolated mitochondria from liver cells (Forner et al., 
2006) and compared their labeling ratios to whole cell lysates from the same sample (Figure 
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4-2C, black bars). Interestingly, proteins from mitochondria showed an average SILAC-ratio 
of 8.6+/-2.4. This shows that the incorporation rates of an organelle are more narrowly 
distributed and distinguishable from that of a whole tissue.  
We next investigated several cell types of the hematopoietic system. Platelets are cell 
fragments which are constantly released by megakaryocytes into the blood stream. They 
have a half live of approximately 7-9 days. We isolated platelets from a SILAC mouse after 
four weeks of labeling and measured incorporation levels of 86% from 241 quantified 
proteins (Figure 4-2D). In contrast, serum albumin, which was also measured within the 
platelet sample due to serum contamination, has a much higher incorporation level 
compared to platelet proteins. Analysis of the red blood cell proteome revealed a 
significantly lower 13C6-lysine incorporation of 75% (Figure 4-2E). Thus, consideration of 
SILAC incorporation rates could aid in determining the origin of the same proteins from 
different cellular pools via their different dynamic incorporation rates.  
To combine SILAC-mouse analysis with cell sorting to obtain an accurately defined cell 
population, we separated CD45R-positive B-lymphocytes from spleen by FACS (Figure 4-2F, 
Figure S3 online). An in solution protein digest was performed from lysates of 1x106 spleen 
cells (Table S2F online). The distribution of measured ratios was 5.4+/-1.3 demonstrating 
that FACS-sorted populations of interest can readily be investigated in the SILAC-mouse. 
Taken together, our results indicate that feeding mice with a SILAC diet is a suitable 
approach to label proteins in vivo and to follow their metabolic incorporation in any organ.  
4.3.3 Complete SILAC-based labeling of F2 mice 
Although the label efficiency was relatively high in many tissues, we found that extending 
the labeling time did not lead to complete labeling. This is likely due to the recycling of 
internal amino acid sources (Doherty et al., 2005).  
 
Figure 4-3 Complete labeling of the F2 generation. (A) Label efficiency of the liver of a two days old mouse of 
the F1 generation. (B) Histograms of liver proteins with the specified percent incorporation at P2 and (C) at P50 
of the F2 generation. The averages of the SILAC ratios and the corresponding percent of the SILAC labeling are 
displayed in the histogram. The analysis encompasses about 100 proteins 
Since labeling rates above 95% are required to perform comparative and quantitative 
proteomics by MS we started feeding our mice over several generations with the heavy diet. 
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Importantly, the consumption of the heavy diet did not affect litter size. The F1 to F4 
offspring developed normally, gained weight within the normal weight gain chart and 
showed normal mating behavior. Furthermore, newborn animals of the F1 generation were 
almost completely labeled and reached about 93 % in blood, brain and liver (Figure 4-3 and 
Figure S4 online). To obtain fully labeled animals to serve as internal standards and to 
investigate if SILAC-labeling could be performed for many generations, we bred F2, F3 and 
F4 mice. These mice contained virtually no unlabeled peptides (Figure 4-3B,C, Figure 5A, 
Table S3 online). 
4.3.4 Proteome of β1 integrin-deficient platelets  
For validation of our in vivo quantitative proteomics approach we analyzed and compared 
protein lysates from 1 integrin deficient and control platelets (Nieswandt et al., 2001). We 
generated 1 integrin-deficient platelets by intercrossing 1 floxed mice ( 1fl/fl) with a 
transgenic mouse expressing an Mx1 promoter-driven, interferon inducible Cre (Mx1-Cre) 
(Brakebusch et al., 2000; Kuhn et al., 1995). We treated ( 1fl/fl; Mx1-Cre) mice with synthetic 
double-stranded RNA (polyinosinic-polycytidylic acid, pI:pC) which triggers endogenous 
interferon production and subsequent Mx1-Cre activity. This leads to deletion of the 1 
integrin gene in all hematopoietic cells including megakaryocytes. To monitor the knockout 
efficiency of 1 integrin, we compared platelets from labeled wild-type animals with platelet 
populations from three groups of mice: (i) non-labeled wild-type platelets, (ii) platelets from 
non-labeled, non pI-pC-induced 1fl/fl; Mx1-Cre mice, and (iii) platelets from non-labeled, pI-
pC-induced 1fl/fl; Mx1-Cre mice (Figure 4-4). All mice were backcrossed on a C57BL/6 
background to reduce genetic variability.   
We quantified about 645 proteins in these platelets and as expected, protein ratios of 
labeled and non-labeled wild-type platelets were tightly distributed with an overall ratio of 
1:1. The quantitative MS analysis revealed complete loss of 1 integrin in platelets from pI-
pC-induced 1fl/fl; Mx1-Cre mice (Figure 4-4F). The proteins with the next highest ratios were 
the dimerization partners of the 1 integrin subunit, strikingly confirming the sensitivity and 
reliability of our SILAC mouse labeling system (Figure 4-4I). In a boxplot analysis 1, 2 and 
6 integrins were all more than ten interquartile ranges away from the median (Table S4 
and Figure S5A online).The complete loss of both  subunits can be explained by the 
formation of a stable integrin heterodimer during the synthesis and transport of the 
complexed integrin subunits to the plasma membrane. Without the correct  integrin 
subunit the  subunit is rapidly degraded (Hynes, 2002). In contrast, the loss of 1 integrin 
has no impact on the expression of other integrins, such as the major platelet 
integrin IIb 3.  
In addition, several other proteins in 1 integrin-deficient platelets were outliers in the 
boxplot (Table S4, Figure S5A online). However, a second independent experiment did not 
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verify these proteins as significantly downregulated. (Figure S5C). In contrast, the 1 integrin 
dimerization partners, 2 and 6 integrins were again strongly reduced (Figure S5C).  
Interestingly the analysis of platelets from non-induced 1fl/fl Mx1-Cre mice also revealed a 
slight down regulation of the 1, 2, and 6 integrin levels compared to labeled wild-type 
platelets (Figure 4-4J). This effect is due to the natural, endogenous /  interferon 
production in the bone marrow causing a low Mx1 promoter activity (Kuhn et al., 1995). The 
detection of this ‘leak’ impressively underscores the sensitivity of our quantitative 
proteomics approach.  
 
Figure 4-4 Analysis of β1 integrin knockout platelets. (A, D, G) Platelets from SILAC labeled wild-type mice were 
mixed with platelets from a non-labeled wild-type control mouse. Comparison of the wild-type SILAC mouse 
with the non-induced, β1fl/fl; Mx1-Cre mice (B, E, H) and with pI-pC induced β1fl/fl; Mx1-Cre (C, F, I). The slight 
decrease of β1 integrin in E is due to Cre activity induced by low endogenous interferon expression. The arrows 
in (F) and (I) label the reduced peak intensity of β1 and α2 integrin. (J) Summary of quantified SILAC-ratios for 
β3, β1, α2 and α6 integrin subunits. White bars represent the ratio between the labeled wild-type wt(heavy) 
animal and non-labeled wild-type animal, grey bars represents SILAC-ratio of wt(h) and non-induced, β1fl/fl, 
and black bar shows the SILAC-ratio between wt(h) and induced β1fl/fl; Mx1-Cre. The error bars show the 
variability of the measured ratios. 
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4.3.5 -Parvin deficiency in heart is compensated by -Parvin induction  
We next wanted to confirm the applicability of our in vivo SILAC approach to analyze the 
proteomes from knockout mice in a solid organ. To this end we compared the proteomes 
from hearts of -Parvin deficient mice with control littermates. As a heavy standard we used 
heart lysates from two weeks old mice of the F4 generation which showed an overall 97.7% 
incorporation of 13C-lysine (Figure 4-5A). To test our quantitation system we mixed “heavy” 
and “light” protein lysates from wild-type hearts in ratios of 1:1, 1:2, and 1:4. As shown in 
(Figure 4-5B), mixing of protein lysates from different heart samples gave rise to SILAC ratios 
that accurately reflected the lysate mixture. 
 
Figure 4-5 Analysis of heart tissue from β-Parvin knockout mice. (A) 
13
C6 lysine incorporation of heart tissue 
from mice of the F4 generation shows a label efficiency of 97.7% (B) Heart tissue from labeled and non-labeled 
animals were mixed 1:1, 1:2, and 1:4. The measured SILAC ratios after in solution digestion were: 0.93+/-0.17 
for 1:1 mix, 0.58+/-0.10 for 1:2 mix, and 0.26+/-0.05 for 1:4 mix). Approximately 300 SILAC protein ratios were 
used for the quantification. (C) Heart tissue from SILAC labeled wild-type mice were mixed with non-labeled β-
parvin (+/+) and β-parvin (-/-) hearts. Arrow indicates the complete absence β-parvin. (D) SILAC-ratios of 
selected proteins 
-Parvin represents the dominant Parvin isoform of the heart, since -Parvin is only weakly 
present and -Parvin is absent from heart. -Parvin deficient mice were generated by 
homologous recombination of a targeting vector in embryonic stem (ES) cells, which lacks 
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exon 2 and 3 of the -Parvin gene (Thievessen and Fässler, will be described elsewhere). -
Parvin deficient mice were viable, fertile and did not show any overt phenotype indicating 
that -Parvin is not essential for mouse development and organ formation. Mass 
spectrometric measurements of whole protein lysates from -Parvin deficient and control 
hearts of 2 weeks old animals showed a complete absence of -Parvin in knockout animals 
(Figure 4-5C,D). Out of 1205 proteins only 4 proteins showed two-fold decrease in their 
abundance compared to wild-type hearts (Table S5 online). Interestingly, lack of -Parvin 
had no dramatic consequence on the level of ILK and PINCH-1, which are the two other 
components of the ILK/Pinch/Parvin complex. The twofold increase of -Parvin in -Parvin 
deficient hearts suggests that the absence of an obvious phenotype is due to compensatory 
up regulation of -Parvin (Figure 4-5C). 
4.3.6 Kindlin-3 deficiency disrupts the red blood cell membrane skeleton  
Kindlin-3-deficient mice die at birth and suffer from severe bleeding, anaemia and pale skin 
colour (Figure 4-7A,B) (Moser et al., 2008). To further validate the power of in vivo SILAC and 
to obtain novel insights into Kindlin-3 function, we performed quantitative proteomics of 
platelets and erythrocytes from Kindlin-3-/- mice.  
Platelet analysis identified Kindlin-3 as the protein with the highest fold-change of more than 
1200 platelet proteins (Table S6 online, Figure S6A online). Interestingly, the levels of 
integrin αIIb and β3 subunits were normal suggesting that the reduced surface levels found 
by FACS (Moser et al., 2008) were due to an impaired integrin trafficking in the absence of 
Kindlin-3 (Figure S6B online). 
We have previously reported that Kindlin-3 (also known as ‘unc-related protein 2’) is present 
in red blood cells (Pasini et al., 2006). This was confirmed by different SILAC incorporation 
levels in platelets (incorporation rate of 6.0) compared to erythrocytes (incorporation rate 
2.1) measured after the initial four weeks labeling period (Figure 4-2, Figure S7A,B online). 
Furthermore, Kindlin-3 gene activity in Ter119-positive Kindlin-3-heterozygous erythroblasts 
was further corroborated by measuring Kindlin-3 promoter driven -galactosidase reporter 
gene activity with FACS (Figure S7C online).  
To investigate whether loss of Kindlin-3 affects erythroid cells we determined and 
quantitatively compared the proteomes from wild-type, Kindlin-3+/- and Kindlin-3-/- 
erythrocytes (Figure 4-6, Table S7 online). Mass spectrometry confirmed a 50% reduction of 
Kindlin-3 in heterozygous and a complete absence of Kindlin-3 in Kindlin-3-/- erythrocytes 
(Figure 4-6A). Out of 881 proteins identified in all three proteomes, more than 50 were two-
fold increased in Kindlin-3-/- erythrocytes and only a few revealed a more than two-fold 
reduction. Interestingly, a large proportion of the up-regulated proteins were annotated to 
be nuclear (Table S7 online).  
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Blood smears from Kindlin-3-/- embryos and P3 animals showed a strong reduction of cells 
when compared to wild-type controls and, in concordance with this proteomic finding, many 
more nucleated erythroblasts (Figure 4-7B,C). In addition, the size and shape of Kindlin-3-/- 
erythrocytes were markedly irregular. 
 
Figure 4-6 Quantitative proteomics of erythrocytes from Kindlin-3-/- mice. (A) Mass spectra of a Kindlin-3 
peptide SILAC pair in Kindlin-3+/+, Kindlin-3+/-, and Kindlin-3-/- erythrocytes. (B) Histogram of SILAC ratios of 
wild-type (white bars) and Kindlin-3-/- erythrocytes (grey bars). The measured ratios were grouped into ratio-
bins and the y axis shows the relative number of detected ratios per bin 
Scanning electron microscopy showed abnormally shaped erythrocytes with striking 
membrane invaginations and protuberances (Figure 4-7D). Red blood cell membrane 
abnormalities are often caused by mutations within membrane skeleton proteins and the 
absence of key components can have drastic consequences on the stability of the red cell 
membrane (Delaunay, 1995). To obtain an explanation for the structural defects we 
quantitatively compared the membrane skeleton proteins from total erythrocytes by SILAC-
based MS. The levels of the most prominent skeleton proteins (e.g. /  spectrin, ankyrin, 
band 3, band 4.1, band 4.2 and actin) did not significantly differ between wild-type and 
Kindlin-3-/- mice.  
Next we determined whether these proteins have formed a stable meshwork which is 
connected with the erythrocyte membrane. To address this question, we isolated the 
erythrocyte membranes (so called red blood cell ‘ghosts’) from wild-type and Kindlin-3-/- 
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mice and compared them to ghosts from SILAC-labeled control animals (Figure 4-7E). 
Quantitative SILAC-based analysis revealed an almost complete absence of ankyrin-1, band 
4.1, adducin-2, and dematin (Figure 4-7F right rows, Table S8 online) while other membrane 
skeleton proteins like /  spectrin and band-3 were not changed. 
 
Figure 4-7 Kindlin-3-deficient erythrocytes show disrupt membrane skeleton. (A) Kindlin-3 knockout mice are 
anemic. (B) Decreased hematocrit in Kindlin-3
-/-
 mutants at embryonic day 15 and P3. (C) Blood smears from 
E15 embryos and P3 wild-type and Kindlin-3
-/-
 mice reveal less erythrocytes and an increased number of 
nucleated erythroblasts. (D) Scanning electron microscopy of wildtype and Kindlin-3
-/-
 erythrocytes. Scale bar 
represents 1μm. (E) “Ghost”-lysates from wild-type, heterozygous and Kindlin-3
-/-
 mice were stained by 
Coomassie blue after SDS-PAGE. Arrows indicate absence of proteins within the membraneskeleton fraction of 
Kindlin-3
-/
- erythrocytes.(F) SILAC-ratio comparison of total erythrocytes (left rows) and the membrane fraction 
(right row). 
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Together these findings show that Kindlin-3 is required for the assembly of a subset of 
proteins within the red blood cell membrane skeleton. Furthermore, the proteomic, 
morphological and functional data provide a clear explanation for the anemia that leads to 
post-natal lethality. 
4.4 Discussion 
So far quantitative gene expression comparisons in higher organisms have been restricted to 
RNA analyses by gene chip approaches. These methods have many advantages, for example 
ready accessibility and the fact that in principle almost all genes can be analyzed on one 
chip. However, because of post-transcriptional regulation as well as regulated protein 
degradation these data do not necessarily predict changes in protein levels within cells or 
tissues. Furthermore, there are specific cell populations, such as the platelets and 
erythrocytes investigated here, that are devoid of mRNA and therefore out of reach for 
these techniques. 
Here we show that SILAC, a versatile and successful method for quantitative proteomics in 
cell culture based systems or microorganisms, can be extended to a mammalian model 
systems. Mice can be SILAC-labeled without any obvious effect on growth, behavior or 
fertility. SILAC food preparation is straightforward and not particularly expensive when 
considering other resources required for the generation and maintenance of knockout 
animals. We chose 13C6-lysine labeling as lysine is not converted into other amino acids. This 
makes endoprotease Lys-C the preferred choice as the proteolytic enzyme. Another 
interesting enzyme for SILAC-mice is Lys-N, which has recently been described as an efficient 
enzyme for proteomics and de-novo peptide sequencing (Taouatas et al., 2008). Organs 
derived from SILAC mice can serve as standards for a large number of subsequent 
experiments, in which wild-type and knockout mice are compared. Importantly, cell types 
such as intestinal epithelium that are difficult to study ex vivo can be analyzed by the in vivo 
SILAC approach. Moreover, the SILAC mouse can serve as a reference model at any biological 
scale, from the whole organ through specific cell types down to intracellular compartments 
or single proteins of interest. As an example, we used SILAC mice to successfully study the 
mitochondrial proteome, which can be extended to investigations in relevant organs from 
metabolic or neurodegenerative disease models. In studies where a large number of mice is 
required – such as in toxicology – labeled organ tissue could be stored used as internal 
standard for each measurement. A labeled SILAC-mouse liver, for example, yields sufficient 
internal standard for more than a thousand measurements. Although not shown here, 
phospho-peptides can also be enriched from SILAC mice and serve as a standard for 
functional and time-resolved phosphoproteomics (Olsen et al., 2006).  
We analyzed the proteomes of cells from three independent knockout mice. In all analyses 
the complete absence of the targeted genes was immediately revealed by the SILAC 
technique. Furthermore, heterozygous Kindlin-3 animals present the expected two-fold 
reduction from wild-type levels, emphasizing the quantitative nature of our proteomic 
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technology. This may be particularly useful in quantifying knockdown efficiencies in 
transgenic RNAi mice. The sensitivity of the SILAC-based quantitation system became 
remarkably obvious by an observation from the β1 integrin inactivation in platelets. Deletion 
of the β1 integrin gene in hematopoietic cells is achieved by the induction of the Mx1-Cre 
transgene through the injection of pI-pC into β1 integrin floxed animals. Even without 
induction of Cre the low expression levels of naturally expressed α/β-interferon activated 
the Mx1-promoter and trigger β1 integrin deletion in a few cells. Even this slight difference 
in total β1 integrin expression proved sufficient for detection by the SILAC method.  
Our proteomic data on platelets of β1-integrin mice showed that although integrins control a 
number of different signaling pathways, the lack of the β1 integrin has no consequences on 
the levels of other proteins in platelets apart from its dimerization partners α2 and α6 
integrins. This may be due to the fact that in resting platelets integrins are inactive and 
signaling into the cell is only induced upon stimulation via molecules like thrombin or 
collagen (Ruggeri, 2002). Further studies using the SILAC-mouse system could focus on 
activation of signaling cascades during platelet aggregation using phosphoproteomics.  
To test the SILAC-based analysis in a solid organ system, we compared the proteomes from 
heart of β-parvin deficient mice with control littermates. The complexity of a tissue, formed 
by different cell types, poses no limitation for the quantitative analysis by mass 
spectrometry. The interpretation of results, however, is more challenging because changes 
in protein levels may result from non cell autonomous defects caused for example by altered 
cell-cell communication rather than cell autonomous defects. 
To study the molecular cause of the anemia observed in Kindlin-3 mutants, we analyzed the 
consequences of this deletion on the proteome of platelets and erythrocytes. Recently, we 
characterized Kindlin-3 as an essential factor for the activation of platelet integrins (Moser et 
al., 2008). Kindlin-3 directly binds to the cytoplasmic tails of both β1 and β3 integrin 
subunits. Its expression is restricted to cells of the hematopoietic system (Ussar et al., 2006). 
Our SILAC based analysis of Kindlin-3 deficient erythrocytes revealed an increased amount of 
nuclear proteins prompting us to investigate consequences of the knockout on this cell type. 
Consistent with the proteomic results, we found an increased number of nucleated 
erythroblasts in blood smears. Furthermore, Kindlin-3 deficient erythrocytes are irregular in 
size and shape. The structural defects of the red blood cell membrane skeleton suggested an 
additional function of Kindlin-3. With the help of the SILAC method we quantitatively 
compared the membrane skeleton proteins of control and Kindlin-3 deficient erythrocytes 
and revealed a critical role of Kindlin-3 in the formation or stabilization of this structure. The 
inner surface of the red blood cell membrane is laminated by a protein network that is linked 
to transmembrane proteins. In humans and mice mutations in genes encoding ankyrin, band 
3, spectrin and protein 4.1 or protein 4.2 cause hereditary spherocytosis or poikilocytosis 
often accompanied with hemolytic anemias (Delaunay, 1995; Peters et al., 1998; Rybicki et 
al., 1995; Shi et al., 1999; Southgate et al., 1996). The dramatic reduction of ankyrin-1, 
protein 4.1 and dematin in membrane preparations from Kindlin-3 deficient erythrocytes 
The SILAC mouse  74   
explains the severe malformations. Thus, loss of Kindlin-3 affects erythropoiesis by 
disrupting the assembly of structural components within the red blood cell membrane 
skeleton. 
In summary, a direct combination of the SILAC technology for quantitative proteomics with 
the large number of powerful mouse models generated by the community is now possible. 
We have demonstrated here how proteomics can be combined with several of the powerful 
technologies already used in this endeavor. We are confident that this technology will help 
to elucidate disease processes and guide novel intervention strategies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
5 Concluding remarks 
 
The research described herein had the aim of using MS-based quantitative proteomics for 
the characterization of in vivo cells. Proteomics has proven its applicability in a variety of cell 
culture models for phenotyping of cell lines, for the deciphering of signal transduction 
pathways after certain stimuli and for the determination of binding partners. The next step 
was to apply this technology in vivo. However, this is not a trivial task: Primary cells have to 
be isolated in a laborious way from tissues, which in general leads to only to a few million 
cells of high purity. This is roughly the equivalent of just one 15-centimeter cell culture dish 
of HeLa cells, the most used cell line in many laboratories. Further challenges arise due to 
the lack of robust quantitation methods like the SILAC approach for experiments involving 
many mice or human material. Taken together, these challenges hampered the in depth 
analysis of in vivo cells using MS-based quantitative proteomics. 
In this thesis, I have shown that quantitative proteomics is applicable to the analysis of rare 
in vivo cell populations and that it can provide direct insights into specific functions of closely 
related cell types. The development of novel label-free quantitation algorithms allowed 
accurate and robust proteome wide quantitation, as shown on the benchmark dataset with 
two mixed proteomes of human and E.coli proteins. This quantitation method without stable 
isotopes is not as accurate as metabolic labeling strategies, but certainly the method of 
choice if isotope labeling is not possible as in the case of the comparative analysis of in vivo 
cells.  
I have further applied this method to conventional dendritic cell subsets, rare populations of 
important orchestrators of the immune system. Isolation procedures of pooled spleens from 
32 mice yielded only 5x106 CD4+ and 2.5x106 of both CD8α+ and DN cDC subsets, making 
proteomic analysis extremely challenging. However using our optimized proteomics 
workflow together with newly developed label-free quantitation algorithms, we were able to 
determine the proteome of cDC subsets to a depth of 5780 proteins, requiring just 20-25 µg 
of sample. This shows the applicability of our developed method for the quantitative analysis 
of rare cell populations. My large-scale proteomic dataset showed strikingly different 
expression of pattern recognition receptors, like the RIG-like helicases RIG-I and MDA5, 
between DC subsets, which prompted us to make functional predictions about these closely 
related cell types. Ex vivo infection of cDC subsets with Sendai virus confirmed our proteomic 
finding and defined a novel important role of CD4+ and DN cDCs in viral infections.  
The third project of my thesis, in which I have been involved, was the generation of the 
SILAC mouse. An inarguable advantage of the SILAC approach is its precise quantitation 
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capability. However, so far SILAC has been limited to cultured cell lines. We described the 
extension of the SILAC technology to the in vivo mouse model. Using a special SILAC diet 
containing only 13C6-lysine enabled us to label the entire mouse, including all tissues such as 
gut, liver or cell populations like B-lymphocytes. The labeled tissues or cell population can 
now be used as internal standards for studying the phenotype of any mouse model under 
any experimental conditions, making the SILAC mouse to a very useful tool for drug 
development.  
In conclusion, the approaches described in my thesis opens the field of MS-based proteomics 
for accurate and robust quantitation of in vivo samples with the possibility for direct 
functional conclusions. 
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